
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4AE2A8AF3080305AE2A002D350F21.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="alzreth">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Alzheimer&#x27;s Research &amp; Therapy">
<meta name="citation_title" content="Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model">
<meta name="citation_author" content="Ting-Ting Pan">
<meta name="citation_author_institution" content="Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author" content="Yan-Yun Sun">
<meta name="citation_author_institution" content="Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author" content="Yi-Fan Shi">
<meta name="citation_author_institution" content="Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author" content="Mei Zhao">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author" content="Naveed Ullah Khan">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author" content="Hai-Yan Chen">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author" content="Wen-Li Ji">
<meta name="citation_author_institution" content="Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author" content="Jie Li">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author" content="Liang Han">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author" content="Quan-Hong Ma">
<meta name="citation_author_institution" content="Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_author_institution" content="Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China">
<meta name="citation_author_institution" content="Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="17">
<meta name="citation_firstpage" content="193">
<meta name="citation_doi" content="10.1186/s13195-025-01840-5">
<meta name="citation_pmid" content="40830501">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/pdf/13195_2025_Article_1840.pdf">
<meta name="description" content="Blood-brain barrier (BBB) dysfunction is an early pathological hallmark of Alzheimer’s disease (AD), occurring prior to amyloid-β (Aβ) accumulation. A key factor contributing to BBB damage in AD is the loss of endothelial expression of low-density ...">
<meta name="og:title" content="Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Blood-brain barrier (BBB) dysfunction is an early pathological hallmark of Alzheimer’s disease (AD), occurring prior to amyloid-β (Aβ) accumulation. A key factor contributing to BBB damage in AD is the loss of endothelial expression of low-density ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366182">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13195-025-01840-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13195_2025_Article_1840.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366182%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366182/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366182/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-alzreth.png" alt="Alzheimer's Research &amp; Therapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Alzheimer's Research &amp; Therapy" title="Link to Alzheimer's Research &amp; Therapy" shape="default" href="https://alzres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Alzheimers Res Ther</button></div>. 2025 Aug 20;17:193. doi: <a href="https://doi.org/10.1186/s13195-025-01840-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13195-025-01840-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Alzheimers%20Res%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer’s disease in a mouse model</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20TT%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ting-Ting Pan</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ting-Ting Pan</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20TT%22%5BAuthor%5D" class="usa-link"><span class="name western">Ting-Ting Pan</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20YY%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yan-Yun Sun</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yan-Yun Sun</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20YY%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan-Yun Sun</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20YF%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yi-Fan Shi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Yi-Fan Shi</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20YF%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi-Fan Shi</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Mei Zhao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Mei Zhao</span></h3>
<div class="p">
<sup>5</sup>Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mei Zhao</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20NU%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Naveed Ullah Khan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Naveed Ullah Khan</span></h3>
<div class="p">
<sup>5</sup>Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20NU%22%5BAuthor%5D" class="usa-link"><span class="name western">Naveed Ullah Khan</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20HY%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hai-Yan Chen</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Hai-Yan Chen</span></h3>
<div class="p">
<sup>5</sup>Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20HY%22%5BAuthor%5D" class="usa-link"><span class="name western">Hai-Yan Chen</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ji%20WL%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Wen-Li Ji</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Wen-Li Ji</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ji%20WL%22%5BAuthor%5D" class="usa-link"><span class="name western">Wen-Li Ji</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jie Li</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jie Li</span></h3>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie Li</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Liang Han</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Liang Han</span></h3>
<div class="p">
<sup>5</sup>Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liang Han</span></a>
</div>
</div>
<sup>5,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20QH%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Quan-Hong Ma</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Quan-Hong Ma</span></h3>
<div class="p">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="p">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ma%20QH%22%5BAuthor%5D" class="usa-link"><span class="name western">Quan-Hong Ma</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Neurology and Clinical Research Center of Neurological Disease, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004 China </div>
<div id="Aff2">
<sup>2</sup>Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215123 China </div>
<div id="Aff3">
<sup>3</sup>MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div id="Aff4">
<sup>4</sup>Department of General Practice, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215004 China </div>
<div id="Aff5">
<sup>5</sup>Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho- Diseases and College of Pharmaceutical Sciences, Soochow University, Block 402, Renai Road 199, Suzhou, Jiangsu 215123 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 6; Accepted 2025 Aug 8; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366182  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830501/" class="usa-link">40830501</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Blood-brain barrier (BBB) dysfunction is an early pathological hallmark of Alzheimer’s disease (AD), occurring prior to amyloid-<em>β</em> (A<em>β</em>) accumulation. A key factor contributing to BBB damage in AD is the loss of endothelial expression of low-density lipoprotein receptor-related protein 1 (LRP1). Endothelial LRP1 is crucial for maintaining BBB integrity and facilitating the transcytosis of A<em>β</em> across the BBB for peripheral clearance. However, LRP1 is also expressed in other neural cell types, such as neurons, where it paradoxically promotes A<em>β</em> generation and tau propagation. These dual roles of LRP1 for different cell types present a challenge for developing effective AD therapy targeting LRP1. Simvastatin (SIM), an HMG-CoA reductase inhibitor, has been shown to induce compensatory upregulation of LRP1 expression. To harness this potential, we designed SIM-loaded Angiopep-2-anchored nanoparticles (S@A-NPs) that can be effectively internalized by endothelial cells. Our findings demonstrate that intravenous (IV) injection with S@A-NPs upregulates endothelial LRP1 expression level, repairs BBB damage, attenuates A<em>β</em> accumulation, mitigates neurodegeneration, and ultimately preserves cognitive function in APP/PS1 mice. These results highlight the potential of endothelial delivery of SIM via nanoparticles to attenuate AD pathogenesis. Our study proposes a novel therapeutic strategy for AD by leveraging nanoparticle-mediated drug delivery.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13195-025-01840-5.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Simvastatin, Nanoparticles, Alzheimer’s disease, LRP1, BBB, Amyloid-<em>β</em>, Neurodegeneration</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders, clinically characterized by progressive memory impairment and executive dysfunction. Its major pathological features include the accumulation of amyloid-<em>β</em> (A<em>β</em>) peptides, with particular pathological ‌contributions‌ from ‌neurotoxic A<em>β</em>, and‌ intracellular tau-containing neurofibrillary tangles [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The accumulation of A<em>β</em> plays a central and early role in triggering pathological progression of AD, contributing to vascular dysfunction [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>], neuroinflammation [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>], impaired synaptic plasticity [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>], and reduced cerebral blood flow (CBF) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Therefore, reducing A<em>β</em> accumulation has become a primary therapeutic strategy for AD. The concentration of A<em>β</em> in the brain is tightly regulated by several processes, including its production through the sequential cleavage of <em>β</em>-amyloid precursor protein (APP) by <em>β</em>-secretase (BACE1) and γ-secretase [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], its transport across the blood-brain barrier (BBB) [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>−<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>] and its clearance via glial phagocytosis [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>− <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p>
<p id="Par3">The BBB is a critical structure for maintaining brain homeostasis, which acts as a defense structure that tightly regulates the exchange of molecules between the blood and brain parenchyma ( [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. By preventing the entry of harmful toxins and pathogens, the BBB ensures a stable and protected environment for optimal neural function. Damage to the BBB has been identified as one of the earliest pathological events in AD, occurring even before A<em>β</em> accumulation ( [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Thus, BBB impairment has been recognized as an early biomarker of aging-related cognitive dysfunction and AD progression. Remarkably, BBB dysfunction alone is sufficient to trigger neurodegeneration and cognitive impairment through mechanisms independent of A<em>β</em> ( [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Furthermore, the cerebral accumulation of A<em>β</em> is determined by the balance between its production and clearance rates, with the A<em>β</em> clearance capacity playing a more critical role ( [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].‌ Among these, the transport of A<em>β</em> from the brain across the BBB to the bloodstream is recognized as the most efficient mechanism for its rapid clearance [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. About one-third of A<em>β</em> is transported out of the brain via the BBB and subsequently cleared by the peripheral organs, and enhancement of peripheral A<em>β</em> clearance decreases brain A<em>β</em> accumulation and prevents AD pathogenesis [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par4">BBB dysfunction is associated with not only the loss of its structural components, such as vascular endothelial cells, astrocytes, pericytes, and junctional complexes, including tight junctions and adherens junctions, but also the aberrant expression of BBB transporters and/or receptors [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Low-density lipoprotein receptor-related protein 1 (LRP1), a transmembrane endocytic and cell signaling protein, is a receptor of 100 diverse ligands, including apolipoprotein E (APOE) [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. APOE is one of risk factors for AD [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. LRP1 expression in brain endothelial cells is essential for maintaining BBB integrity and function [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Mechanistically, the absence of LRP1 in endothelial cells results in the autonomous activation of the cyclophilin A-matrix metalloproteinase-9 (MMP-9) pathway in the endothelium, causing the loss of tight junctions and structural impairment of the BBB [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Endothelial LRP1 together with the receptor for advanced glycosylation end-products (RAGE), bidirectionally mediates the transport of A<em>β</em> between the blood and the brain: the influx of A<em>β</em> from the blood into the brain across the BBB relies on RAGE expression in the luminal surface of endothelial cells [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>], while the efflux of A<em>β</em> from the brain depends on LRP1 expression on the abluminal side of the endothelial cells [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. The A<em>β</em> efflux involves sequential steps: Following binding to abluminal LRP1, A<em>β</em> is internalized by endothelial cells through either clathrin-coated vesicle formation (PECAM-1 assisted) or phagosome generation via APOE-LRP1 complexes. This internalized A<em>β</em> then undergoes transcytosis via vesicular transport from the abluminal to the luminal membrane for direct release into the circulation. Alternatively, LRP1 facilitates A<em>β</em> transfer to luminal efflux transporters (P-gp/ABCB1 or ABCC1) for exocytosis-mediated clearance [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Notably, RAGE mediates the transport of peripheral A<em>β</em> into the brain, thereby reducing its accumulation in the periphery, and regulates the influx of A<em>β</em> from the circulation into the brain compartment [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Thus, the BBB has a dual role in A<em>β</em> transport.</p>
<p id="Par5">Earlier studies revealed that the levels of endothelial LRP1 decrease with aging [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>] and are almost absent from blood vessels in the brains of AD patients [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>], and AD animal models [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. The loss of endothelial LRP1 is a causative factor contributing to progressive BBB impairment [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>] in both normal aging [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] and AD brains [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], which is followed by neurodegeneration and cognitive deficits. Thus, in ‌the human AD brain, endothelial cells exhibit downregulation of endothelial LRP1 and the upregulation of RAGE [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>], which disrupts the A<em>β</em> influx-efflux equilibrium and exacerbates A<em>β</em> accumulation in the AD brain‌. It has been reported that deletion of LRP1 in the endothelial cells impairs the efflux of A<em>β</em>, resulting in the accumulation of A<em>β</em> in the brain and defective spatial memory in 5 × FAD mice, an AD mouse model [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. These findings highlight a protective function of endothelial LRP1 against neurodegeneration and A<em>β</em> accumulation in the brain, suggesting that enhancing or restoring the expression of LRP1 in the endothelial cells is a promising strategy for mitigating AD-related cognitive decline.</p>
<p id="Par6">However, it is worth noting that LRP1 is also expressed in neurons, astrocytes, and microglia in addition to vascular compartments‌. Astrocytic LRP1 mediates the uptake and degradation of A<em>β</em> [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Microglial LRP1 exhibits a conflicting role, either attenuating [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>] or exacerbating [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] neuroinflammation, depending on distinct context. Neuronal LRP1 plays a role in driving both the production [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>] and the clearance [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>] of A<em>β</em>, with its function in driving production outweighing its role in clearance [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Deficiency of endogenous LRP1 leads to attenuated overall A<em>β</em> load due to ‌reduced Aβ production and clearance [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. LRP1-mediated endocytosis of neuronal A<em>β</em><sub>42</sub> is associated with increased A<em>β</em> aggregation and neuronal toxicity [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. A recent study observed that neuronal LRP1, an important regulator of tau protein endocytosis, is required for tau propagation. Reducing neuronal LRP1 suppresses tau spread in the brain [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Thus, due to the paradoxical functions of LRP1 in distinct cell types, precise therapeutic strategies targeting LRP1 in a cell type-dependent manner are needed‌. Restoring the endothelial LRP1 levels while avoiding ‌upregulation of neuronal LRP1‌ may represent ‌a potential therapeutic strategy‌ for AD.</p>
<p id="Par7">Simvastatin (SIM) is a clinically commonly used lipid-lowering drug and an inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. SIM through two established molecular pathways to upregulates LRP1 expression. First, as an HMG-CoA reductase inhibitor, SIM suppresses the cholesterol biosynthesis pathway, thereby reducing levels of key isoprenoids, such as arnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>–<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. This reduction inactivates Rho GTPases, which activate PPARγ, a transcription factor that directly promotes LRP1 gene expression [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>, <a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Second, SIM concurrently inhibits sterol regulatory element-binding protein 2 (SREBP-2) activity, a transcriptional repressor of LRP1 [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>–<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>], effectively derepressing LRP1 synthesis.</p>
<p id="Par8">SIM has been shown to increase LRP1 expression in brain microvascular endothelial cells, thereby inhibiting the accumulation of neurotoxic A<em>β</em> caused by HIV-1 infection [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. Oral gavage treatment with SIM elevates LRP1 expression in murine brain capillary cells isolated from 3 × Tg AD mice and facilitates the clearance of A<em>β</em> across the endothelial barrier [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Furthermore, oral delivery of SIM reverses cerebrovascular impairment and reduces CBF and the accumulation of soluble A<em>β</em> in AD mice. Utilizing SIM to enhance LRP1 expression represents a highly promising strategy for ameliorating AD pathology [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>–<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. However, SIM administration fails to reduce A<em>β</em> plaque deposition and normalize cholinergic function and memory deficits at the advanced stage of pathology [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. A recent study reported that subcutaneous (SC) administration of SIM impairs hippocampal synaptic plasticity, leading to cognitive decline in adult C57BL/6J mice [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. These findings suggest that systemic administration of SIM has limited efficacy in AD therapy, even causing adverse effects, possibly due to the upregulation of LRP1 in multiple cell types, such as neurons and glia. Therefore, specific delivery of SIM to brain endothelial cells may be a promising therapeutic strategy for AD by selectively enhancing endothelial LRP1 expression level.</p>
<p id="Par9">To achieve this purpose, we designed SIM-loaded Angiopep-2-anchored nanoparticles (S@A-NPs), which consist of a PLGA-PLL carrier sphere, a PEG linker material, an Angiopep-2 targeted ligand, and SIM. SIM was encapsulated in the PLGA-PLL carrier sphere, while Angiopep-2 was attached to the outer surface of the sphere via the PEG linker. Among them, the Angiopep-2 ligand binds LRP1 and facilitates LRP1-mediated endothelial internalization of S@A-NPs. Following intracellular release, SIM upregulates endothelial LRP1 expression, creating a positive feedback loop that enhances subsequent nanoparticle internalization (Fig. <a href="#Fig1" class="usa-link">1</a>). Through this “self-promoting” manner, S@A-NPs display higher uptake efficiency by brain microvascular endothelial cells and a greater capability to penetrate the brain [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. We analyzed the potential therapeutic function of S@A-NPs in AD using APP<sub>swe</sub>/PS1<sub>dE9</sub> (APP/PS1) transgenic mice, which exhibit many key features of AD pathology, including BBB impairment [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>], A<em>β</em> accumulation [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>], neuroinflammation, synaptic loss, and cognitive deficits [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>, <a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. These mice are widely used in AD preclinical studies. Upon intravenous (IV) injection, S@A-NPs were up taken by brain endothelial cells, where they upregulated LRP1 expression. Administration of S@A-NPs specifically upregulated endothelial LRP1 expression level, alleviated BBB damage, reduced A<em>β</em> burden, and ameliorated neuroinflammation, neurodegeneration, and cognitive deficits in APP/PS1 transgenic mice. Furthermore, we found that S@A-NPs suppressed the amyloidogenic cleavage of APP while enhancing the transport of A<em>β</em> across the BBB from the brain. These results indicate that S@A-NPs mitigate AD pathogenesis by increasing endothelial LRP1 levels. The present study highlights endothelial cell-specific SIM delivery as a novel approach for AD therapy.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/0da58a042dbc/13195_2025_1840_Fig1_HTML.jpg" loading="lazy" id="d33e735" height="559" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic description of LRP1-targeted S@A-NPs. S@A-NPs comprise a carrier sphere PLGA-PLL, a linker material PEG, a targeted ligand Angiopep-2, and SIM. SIM is encapsulated in a carrier sphere PLGA-PLL, and the outer side of the sphere is connected to Angiopep-2 by the linker material PEG. Among them, Angiopep-2 ligates LRP1 to drive cellular internalization and help efficient intracellular delivery of S@A-NPs into endothelial cells. Once released cellularly, SIM enhances LRP1 expression, which, in turn, accelerates the uptake of the nanoparticles by the endothelial cells. Through this “Self-promoting” manner, S@A-NPs display higher uptake efficacy by brain microvascular endothelial cells. The image was adapted as described [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. The diagram created with BioRender.com and released under a Creative Commons Attribution-Non Commercial No Derivs 4.0 International license</p></figcaption></figure></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Materials</h3>
<p id="Par11">Poly (D, L-lactide-co-glycolide) (PLGA, Cat. 719900, acid-terminated, lactide: glycolide 50:50, MW 38,000–54,000) and poly (<em>ε</em>-carbobenzoxyl-L-lysine) (PLL, Cat. P4510, MW 500-4,000) were purchased from Sigma. <em>α</em>-Malemidyl-u-N-hydroxysuccinimidyl polyethyleneglycol (NHS-PEG-MAL, MW 5,000) and NHS-PEG-Cy3 (Cat. PG2-NSS3) were purchased from Nanocs. TCEP-HCl (Pierce™ 20490) was bought from Thermo Scientific. Polyvinyl alcohol (PVA-403) was obtained from Kuraray (Japan). Angiopep-2 with cysteine (Cys) on its C-terminal (TFFYGGSRGKRNNFKTEEYC) was synthesized by Nanjing Peptide Biotech Ltd (Nanjing, China). The hydrophobic C-terminus accommodates Cys’s hydrophobicity and preserves the hydrophilic N-terminal receptor-binding domain [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>, <a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. This design enables stable thioether bond formation between the thiol group of the C-terminal Cys and the maleimide group in NHS-PEG-MAL, ensuring efficient nanoparticle conjugation without structural compromise. Thus, The C-terminal Cys can stabilize the structure of Angiopep-2 [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>, <a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>] and assist in carrying nanoparticles [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. SIM was purchased from Innochem (Beijing, China).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cell culture and animals</h3>
<p id="Par12">bEND.3 mouse cell line of BMECs was purchased from ATCC. Cells were grown in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 µg/mL streptomycin in a 37 ℃ incubator containing 5% CO<sub>2</sub>.</p>
<p id="Par13">APP/PS1 double transgenic mice express mutant human amyloid precursor protein (APPswe) and presenilin 1 (PS1dE9) under the mouse prion protein promoter. The genetic background of APP/PS1 transgenic mice used for the present study is C57BL/6J. APP/PS1 transgenic mice (stock number 034829) and C57BL/6J mice (stock number 000664) were purchased from the Jackson laboratory and genotyped through tail clips and subsequent PCR analysis of genomic DNA. Female ICR mice of 20–25 g body weight were purchased from the Department of Experimental Animals, Soochow University. All experimental procedures were approved by the Ethics Committee of Soochow University and conformed to the Institutional Animal Care and Use Committee Guidelines of Soochow University and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines for the ethical treatment of animals. The approval numbers are 202302A0391 and SUDA20241121A07. Efforts were made to minimize the number of animals used. All mice were group-housed with 3–5 same-sex cage mates in standard mouse cages in a pathogen-free barrier facility under a 12-h light-dark cycle with lights on at 07:00 and a controlled temperature range of 22–25 ℃. Food and water were provided ad libitum.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Antibodies</h3>
<p id="Par14">Rabbit anti-LRP1 (ab92544, Abcam), Rat anti-CD31 (550274, BD), Mouse anti-NeuN (94403, CST), Rat anti-NeuN (ab279297, Abcam), Rabbit-anti-GFAP (3670T, CST), Goat-anti-IBA-1 (AB5076, Abcam), Goat anti-PDGFR<em>β</em> (AF385, R&amp;D systems), Mouse anti-A<em>β</em>-6E10 (803015, biolegend), Rabbit anti-synaptophysin (SYN) (ab32127, Abcam), Rabbit anti-ZO1 (ab276131, Abcam), Rabbit anti-Occludin (ab216327, Abcam), Rabbit anti-Claudin 5 (AF5216, AffinitY), Rabbit anti-RAGE (ab216329, Abcam), Mouse anti-APP (MAB348, Merke), Mouse anti-BACE1 (NBP2-37261, Novus), Mouse anti-GAPDH (FD0063-100, FD), <em>β</em>-actin(66009-1, Proteintech), Alexa Fluor 555 Donkey anti-Rabbit (A32794, Invitrogen), Alexa Fluor 488 Donkey anti Rabbit (A21206, Invitrogen), Alexa Fluor 555 Donkey anti Mouse (A32773, Invitrogen), Alexa Fluor 488 Donkey anti Mouse (A32766, Invitrogen), Alexa Fluor 488 Donkey anti Goat (A11055, Invitrogen), Alexa Fluor 488 Donkey anti-Rat (A21208, Invitrogen), and HRP AffiniPure Goat anti-Mouse IgG (H + L) (FD0142, FD), HRP AffiniPure Goat anti-Rabbit IgG (H + L) (FD0128, FD) were used.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Preparation of S@A-NPs</h3>
<p id="Par15">The starting material, PLGA-PLL, was synthesized via coupling using dicyclohexyl carbodiimide, following a previously reported method [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. S@A-NPs were prepared using the emulsion solvent evaporation technique. In a typical synthesis, 100 mg PLGA-PLL dissolved in 2 mL ethyl ether containing 10 mg SIM was added dropwise into 4 mL 2.5% PVA under simultaneous vortex mixing and sonication to form an oil/water emulsion. This emulsion was then transferred into a beaker containing 0.3% PVA and stirred overnight. The resulting NPs suspension was first centrifuged at 1,000 rpm for 5 min to remove bigger particles and unencapsulated SIM aggregates. Subsequently, the supernatant was subjected to centrifugation at 30,000 rpm for 20 min to collect the NPs. The NP pellet was resuspended in PBS (pH 7.4) and reacted with 10 mg NHS-PEG-MAL or NHS-PEG-Cy3 for 1 h at room temperature to conjugate the PEG-MAL or PEG-Cy3 linker. The suspension was centrifuged to remove excess, unreacted PEG-MAL or PEG-Cy3, and the PEGylated NP pellet was collected. This pellet was resuspended in PBS (pH 7.4) and then reacted with Cys-modified Angiopep-2 in the presence of TCEP-HCl for 1 h at room temperature. The molar ratio of Angiopep-2 to PEG-MAL or PEG-Cy3 was maintained at 1:10 to achieve a 10% modification. Unreacted Angiopep-2 was removed by centrifugation. The final NPs were suspended in NS and lyophilized for storage and subsequent characterization. The surface density of PEG-Cy3 on the NPs was quantified by measuring the CY3<sup>+</sup> fluorescence intensity. To analyze the distribution of CY3-conjugated S@A-NPs/A-NPs in the brain, five-month-old C57BL/6J mice were intravenously injected with CY3-conjugated A-NPs/S@A-NPs (100 mg NPs kg<sup>− 1</sup>) twice at a frequency of once per 12 h. At 24 h after the final injection, mice were deeply anesthetized with 4% v/v isoflurane and transcardially perfused with 4% paraformaldehyde (PFA).</p></section><section id="Sec7"><h3 class="pmc_sec_title">Biological distribution analysis of SIM</h3>
<p id="Par16">SIM accumulation and concentration analyses in the brain were conducted as previously described [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. The SIM loading efficiency in S@A-NPs was measured as 8.6% [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. To examine the intracranial kinetics of SIM, female ICR mice were intravenously injected with free SIM (8.6 mg kg<sup>− 1</sup>) or S@A-NPs (8.6 mg SIM kg<sup>− 1</sup>) dissolved in normal saline (NS) once [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. At 2, 12, and 24 h post-injection, mice were perfused with PBS (pH 7.4), and their brains and other organs were collected and weighed for SIM analysis using high-performance liquid chromatography (HPLC). To assess the accumulative effects of multiple dosing, ICR mice received IV injection of free SIM or S@A-NPs seven times either daily or every two days. At 24 h after the final injection, the mice were perfused with PBS (pH 7.4), and their brains were collected for SIM analysis using HPLC. HPLC analysis was performed using a C<sub>18</sub> column with a mobile phase of methanol and 0.02 mol L<sup>− 1</sup> monopotassium phosphate in water (85:15, v/v) at a flow rate of 1.0 mL min<sup>− 1</sup>. The column temperature was maintained at 23 ℃, and detection was conducted at a wavelength of 238 nm. The injection volume for each sample was 20 µL.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Drug treatment</h3>
<p id="Par17">Male APP/PS1 heterozygous mice and age-matched wild-type (WT) mice were used in the present in vivo study. The mice were randomly divided into four groups: wild-type mice administered with NS (WT + NS), wild-type mice administered with S@A-NPs (WT + S@A-NPs), APP/PS1 mice administered with NS (TG + NS), and APP/PS1 mice administered with S@A-NPs (TG + S@A-NPs). At 5.5 months of age, APP/PS1 mice or WT mice were intravenously injected with S@A-NPs (7.85 mg SIM kg<sup>− 1</sup>) through tail veils at a frequency of once per two days for 2–3 months. For BBB functional analysis and A<em>β</em> clearance assay, 6-month-old APP/PS1 or WT mice were intravenously injected with S@A-NPs (7.85 mg SIM kg<sup>− 1</sup>) through tail veils at a frequency of once per two days for 1 month. The mice injected with NS were taken as control.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Immunofluorescence staining and image analysis</h3>
<p id="Par18">The mice were deeply anesthetized with 4% v/v isoflurane and transcardially perfused with PBS. Brain tissues were collected and post-fixed in 4% PFA for 4 h at 4 ℃, and then dehydrated through a gradient of 15% and 30% sucrose. The brain tissue was then embedded in OCT embedding medium and sectioned into 20 μm thick slices using a Microtome cryostat (CM1950, Leica). For immunofluorescence staining, brain slices were washed with PBS and PBST (PBS with 0.3% or 0.5% TritonX-100), and subsequently blocked with 10% fetal bovine serum (FBS) diluted with PBST for 1 h at room temperature. Brain slices were incubated with primary antibodies overnight at 4 ℃. After three washes with PBS, the slices were incubated with the corresponding secondary antibody for 1 h at room temperature. The slides were mounted with DAPI-containing mounting medium (0100 − 20, Southern Biotech), and images were captured under the Zeiss LSM 900 confocal laser scanning microscope with a 20 × objective (NA 0.8, WD 0.55 mm) provided a broader view, while a 40 × objective (NA 1.3, WD 0.21 mm) provided more detail. Laser excitation wavelengths include 405 nm (DAPI channel); 488 nm (FITC channel); 561 nm (TRITC/CY3 channel); 640 nm (Alexa Fluor 647 channel). Exposure time varied from 300 to 600 milliseconds. 5–10 random fields of view per brain region (hippocampus and cortex) were captured.</p>
<p id="Par19">All images were analyzed using the ImageJ software (NIH, Bethesda, MA, USA). The percentage of CY3<sup>+</sup>marker<sup>+</sup> cells was calculated by dividing the number of CY3<sup>+</sup> marker<sup>+</sup> cells by the total number of marker<sup>+</sup> cells in the brain. The mean fluorescence intensity (MFI) of LRP1 and BACE1 in endothelial cells, neurons, or CY3<sup>+</sup> cells was quantified by manually selecting the fluorescence signals. For the area of A<em>β</em> plaques quantification, the total area occupied by A<em>β</em> plaques in the respective regions of interest was measured, and the number of A<em>β</em> plaques in these regions was counted. For neuroinflammation analysis, the total area of GFAP and IBA-1 staining within the corresponding regions of interest was quantified. To quantify synaptic loss, the SYN<sup>+</sup> MFI in the mossy fiber layer of the CA3 was measured. The areas of ZO1<sup>+</sup>, Claudin5<sup>+</sup>, and Occludin<sup>+</sup> staining within brain endothelial profiles were determined using the ImageJ area measurement tool. The percentage of ZO1<sup>+</sup>, Claudin5<sup>+</sup>, and Occludin<sup>+</sup> areas was calculated by dividing ZO1<sup>+</sup>, Claudin5<sup>+</sup>, and Occludin<sup>+</sup> fluorescence signal areas by the total endothelial areas.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Western blotting</h3>
<p id="Par20">Protein lysates from the cortex and hippocampus were extracted in brain lysis buffer (10 mM Tris, pH 9.0, 150 mM NaCl, 0.5% TritonX-100, 1% sodium deoxycholate, 0.5% SDS, 2 mM EDTA) containing a protease and phosphatase inhibitor cocktail (<a href="https://www.ncbi.nlm.nih.gov/nuccore/B14002" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">B14002</a>; <a href="https://www.ncbi.nlm.nih.gov/nuccore/B15001" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">B15001</a>, Bimake). Cultured cells were lysed with RIPA lysis buffer (P0013D, Beyotime) containing a protease and phosphatase inhibitor cocktail for 30 min on ice. Samples were centrifuged at 14,000 × g for 15 min at 4 ℃, and supernatants were collected. Lysates were subjected to SDS-PAGE and transferred to a polyvinylidene fluoride membrane (IPVH00010, Merck Millipore). The membranes were blocked with 5% non-fat dry milk (BBI) in Tris-buffered saline (TBST, pH 7.5) (20 mM Tris, 150 mM sodium chloride, 0.1% Tween-20) at RT for 1 h, and then incubated with primary antibodies diluted in TBST overnight at 4 ℃. The membranes were washed with TBST and incubated with HRP-conjugated secondary antibodies (FD) at RT for 1 h. The protein signals were detected by ECL (Merck Millipore, WBKLS). Images were captured with an E-Gel Imager (E-Blot, China). The intensity of each protein signal on the membrane was measured as a grayscale value using ImageJ software (NIH, Bethesda, MA, USA), corrected for background intensity, and normalized to the internal control.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Effect of SIM on LRP1 expression in bEND.3 cells</h3>
<p id="Par21">To assess the in vitro expression of LRP1 in bEND.3 cells by western blot, 1.4 × 10⁵ bEND.3 cells were plated in 6-well plates for overnight. Subsequently, cells were treated with SIM at concentrations of 100 nM, 500 nM, and 1 µM for 36 h. In addition, cells were treated with either free SIM, A-NPs, or S@A-NPs at SIM concentration of 1 µM for 36 h. Cell lysates were mixed with the appropriate amount of SDS sample loading buffer (5×), boiled at 98 °C, centrifuged, and then separated by SDS-PAGE.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Enzyme-linked immunosorbent assay (ELISA)</h3>
<p id="Par22">To quantify A<em>β</em>, tissues from the cortex or hippocampus were homogenized in brain lysis buffer. Total protein levels were determined using a BCA assay kit (23227, ThermoFisher). Then, the soluble supernatant fractions were collected after centrifugation at 35,000 × g for 30 min at 4 ℃. The insoluble fraction in the precipitate was dissolved in 70% formic acid on ice for 2 h, and the supernatant was collected after centrifuged at 12,000 × g for 1 h at 4 ℃. The supernatant was neutralized with 1 M TP buffer (1 M Tris, 0.5 M Na<sub>2</sub>HPO<sub>4</sub>) to a neutral pH. Blood plasma was collected by centrifugation at 1,000 × g for 10 min at 4 ℃. The amounts of A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> were quantified using human A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> ELISA kits (KHB3441; KHB3482, Invitrogen) following the manufacturer’s instructions. The absorbance was read at 450 nm using a TECAN infinite M200 Pro multifunctional microplate reader.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Quantitative realtime PCR</h3>
<p id="Par23">Total RNA was extracted from brain tissue samples using TRIzol reagent (Invitrogen) according to the manufacturer’s protocol. Complementary DNA (cDNA) was synthesized from 1.0 µg total RNA using a reverse transcription kit (Vazyme Biotech Company Limited, China). SYBR qPCR Master Mix (Vazyme Biotech Company Limited, China) was used for quantitative PCR in a final volume of 10 µL on a 7500 Real-Time PCR System (ABI) under the following conditions: 95 ℃ for 30 s, followed by 40 cycles of amplification (95 ℃ for 10 s and 60 ℃ for 30 s). The average threshold cycle (Ct) of fluorescence units was applied to analyze the mRNA levels, which were normalized to GAPDH. qPCR primers are as follows: TNF-α (forward: 5’CTGAGGTCAATCTGCCCAAGTAC; reverse: 5’CTTCACAGAGCAATGACTCCAAAG), IL-<em>β</em> (forward: 5’CTAAAGTATGGGCTGGACTG; reverse: 5’AGCTTCAATGAAAGACCTCA), IL-6 (forward: 5’GAGGATACCACTCCCAACAGACC; reverse: 5’AAGTGCATCATCGTTGTTCATACA), and GAPDH (Forward: 5’GAAGGTCGGTGTGAACGGAT; reverse: 5’AATCTCCACTTTGCCACTGC).</p></section><section id="Sec14"><h3 class="pmc_sec_title">Preparation of A<em>β</em> oligomers</h3>
<p id="Par24">A<em>β</em> oligomers were prepared according to a previously established method [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. Human A<em>β</em><sub>42</sub> (Shanghai RovoBiotech, Cat. No. 22JW06579) was dissolved in hexafluoro isopropanol (HFIP) (H811026, Macklin) to generate monomeric A<em>β</em>. The HFIP-treated monomer solution was lyophilized and reconstituted in DMSO in a stock concentration of 5 mM. A<em>β</em> oligomerization was induced by diluting the monomer stock to 200 µM in ice-cold PBS, followed by overnight incubation at 4 ℃. The solution was centrifuged at 14,000 × g for 10 min at 4 ℃, and the supernatant containing oligomeric A<em>β</em><sub>42</sub> was collected. Oligomer quality was confirmed by 13% Tris-SDS PAGE and western blotting with an anti-A<em>β</em> antibody. For fluorescent labeling, 100 µL of oligomeric A<em>β</em> (200 µM) was incubated with 4 µL Super Fluor 555 NHS ester (Bioesn) in PBS containing 0.1 M sodium bicarbonate buffer (pH 8.3) for 30 min at room temperature with gentle mixing. Unconjugated dye was removed using an Amicon Ultra 3k ultrafiltration cube (UFC5003, Millipore).</p></section><section id="Sec15"><h3 class="pmc_sec_title">A<em>β</em> clearance assay</h3>
<p id="Par25">Mice were deeply anesthetized using 2% v/v isoflurane and mounted on a stereotactic frame (71000-M, RWD). Holes were drilled at the injection site after the skull was exposed. Super Fluor 555 NHS ester-labelled A<em>β</em> oligomers were loaded into a 10 µL syringe (Gaoge, China), and 1 µL was injected with a rate of 200 nL min<sup>− 1</sup> into the targeted regions (dentate gyrus (DG): Anteroposterior (AP) = − 2.0 mm, mediolateral (ML) = -1.3 mm, dorsoventral (DV) = -2.2 mm) [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. The needle was left in place for an additional 5 min before being slowly withdrawn. To minimize potential brain tissue damage, a unilateral injection (left hemisphere) was performed in this study rather than a bilateral injection. After 48 h, mice were deeply anesthetized using 4% v/v isoflurane and transcardially perfused with 4% PFA. The entire injection site was sectioned and imaged as described above, and consecutive sections spaced 20 μm apart. The area occupied by fluorescence signals in all brain slices was manually delineated and measured using Image J software. The sum of the fluorescent signal area across all brain sections represents the area of A<em>β</em> residue that could not be cleared.</p></section><section id="Sec16"><h3 class="pmc_sec_title">BBB leakiness assay</h3>
<p id="Par26">Mice were injected with 0.1 mL of 10-kDa and 40-kDa FITC-conjugated dextran (40 mg mL<sup>− 1</sup>, Sigma) via tail vein. After 15 min, the mice were deeply anesthetized using 4% v/v isoflurane and transcardially perfused with 20 mL of ice-cold PBS. The brains were collected and frozen in liquid nitrogen for at least 5 min, and subsequently stored at -80 ℃ refrigerator until sectioning. FITC-dextran extravasation in brain cryosections (10 μm) was imaged using Olympus VS 200. The fluorescence area of FITC-dextran in the cortex and hippocampus coronal sections was measured using Image J software. The extent of FITC-dextran extravasation, indicating BBB disruption, was calculated based on the fluorescence area. More than three images were acquired within the region of interest (ROI) for each mouse tissue section.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Behavioral tests</h3>
<p id="Par27">The experimenter was blinded to the groups during testing. All behavioral tests were performed in a dimly lit room without noise interference. Tests were recorded using Any-Maze 7.2 (Stoelting, CO, USA). The experimental apparatus was cleaned with 30% ethanol between trials to remove odors of the tested subjects.</p>
<p id="Par28">Open Field Test: Experiments were conducted in a 40 × 40 × 40 cm cubic chamber. Each mouse was gently placed at the center of the arena, and spontaneous locomotor parameters, including total distance traversed and average speed, were recorded over a 10-minute period.</p>
<p id="Par29">New object recognition (NOR): Mice were placed in a 40 × 40 × 40 cm box equipped with a camera on top for habituation trial over three consecutive days. Following habituation, two identical objects, A<sub>1</sub> and A<sub>2,</sub> were placed diagonally in the box, 8 cm away from both walls. Mice were allowed to explore for 10 min, and the time spent sniffing or chewing the object was recorded as exploratory activity. After 90 min, one object (A<sub>1</sub>) was replaced with a novel object (B). Mice were then allowed to explore for another 10 min. The object preference index was defined as the ratio of time spent on object A<sub>1</sub> to the total time spent on objects A<sub>1</sub> and A<sub>2</sub> in the first round of testing. The recognition index was defined as the ratio of time spent on object B to the total time spent on both object B and A<sub>2</sub> in the second round of testing. Object Location Test (OLT) was performed in the same box used for the NOR test. Mice were allowed to freely explore the apparatus, which contained intramural cues on the walls for 5 min to enable habituation. After a 15–30 min interval, the mice were returned to the box and exposed to two identical objects, A<sub>1</sub> and A<sub>2,</sub> placed equidistant from the side walls. Mice were allowed to explore for 10 min freely. After 24 h, object A<sub>2</sub> was removed to a different location within the box, and the mice were allowed to freely explore for 5 min. The object preference index and the recognition index were defined as the ratio of time spent on object A<sub>2</sub> to the total time spent on object A<sub>1</sub> and A<sub>2</sub> during two respective rounds of testing. Mice with normal memory typically prefer the new object or the object in the novel location due to their natural curiosity, resulting in a higher recognition index. In contrast, mice with cognitive deficits tend to spend similar duration of time exploring both the novel and old locations, resulting in a reduced recognition index. Thus, the object preference index value approaching 50% indicates the absence of inherent preference for either object in mice, while the recognition index ≥ 60% demonstrates intact healthy recognition memory.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par30">All data analyses were performed using GraphPad Prism 8.0 to produce graph values. The graph values are presented as the mean ± standard error of the mean (SEM). All statistical analysis was performed using SPSS 26.0. The number of mice included in each experiment was based on standards established in the literature rather than being predetermined by statistical methods. The experimental design for each assay is described in the subsection below. Tests for normality and equal variances were used to determine the appropriate statistical test to apply. Data were analyzed using Student’s t-test (a comparison of the difference between the two groups) and one-way ANOVA (a comparison of the differences between multiple groups) followed by LSD or Dunnett T3 post hoc tests. The <em>P</em>-value indicates significance, and <em>p &lt;</em> 0.05 was considered for the significance level for all analyses; * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01, *** <em>p</em> &lt; 0.001.</p></section></section><section id="Sec19"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec20"><h3 class="pmc_sec_title">Intravenously delivered S@A-NPs penetrate the brain and distribute in the endothelial cells</h3>
<p id="Par31">LRP1 is expressed on the luminal and abluminal membrane of brain microvascular endothelial cells [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. The interaction between LRP1 and Angiopep-2-functionalized nanocarriers promotes endothelial cell uptake of drug cargo, facilitating its subsequent internalization for brain delivery [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>, <a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. S@A-NPs exhibited a spherical morphology with diameters ranging from 53.0 ~ 100.2 nm under transmission electron microscopy (TEM) observations [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Dynamic light scattering (DLS) measurements showed that the freshly prepared S@A-NPs had an average hydrodynamic diameter of 104.0 nm and a ζ-potential of -3.6 mV [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. In vitro release kinetics assessed via HPLC revealed that S@A-NPs released 66.24% SIM within 24 h, achieving near-complete release (~ 100%) over 5 days in a pH-independent manner [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. In this study, we further confirmed the brain delivery efficacy of S@A-NPs by comparing the biodistribution between free SIM and S@A-NPs in the brains of adult mice. Mice treated with S@A-NPs via a single IV injection exhibited a higher brain SIM concentration than those receiving free SIM. The drug concentration in the brain reached the maximum at 2 h after IV injection and gradually decreased over time (Fig. <a href="#Fig2" class="usa-link">2</a>a-b, Supplementary Fig. <a href="#MOESM1" class="usa-link">1</a>a), suggesting a typical clearance dynamic of S@A-NPs. We next examined the accumulation of SIM in the brains of the mice that received seven consecutive IV injections of S@A-NPs. The results showed a significant intracranial increase in SIM accumulation in S@A-NPs-treated mice compared to those injected with free SIM at all investigated post-injection time points. Notably, SIM concentrations in the brains of S@A-NP-administered mice were higher on day 7 post-injection than on day 1 post-injection, indicating a gradual accumulation of SIM in the brain following the 7-day consecutive injection regimen (Fig. <a href="#Fig2" class="usa-link">2</a>c-d, Supplementary Fig. <a href="#MOESM1" class="usa-link">1</a>b). This intracranial increase in SIM accumulation can be attributed to the autocatalytic effect of LRP1 up-regulation mediated by S@A-NPs [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Importantly, compared with free SIM, the S@A-NP delivery system did not alter peripheral distribution pattern of SIM with the liver, spleen, kidney, and lung as the major distribution tissues (Supplementary Fig. <a href="#MOESM1" class="usa-link">1</a>c-f). Thus, continuous injections of S@A-NPs at intervals of less than or equal to 2 days could maintain the steady intracranial SIM concentration, supporting its potential use for long-term AD therapy.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/1c4598e959e8/13195_2025_1840_Fig2_HTML.jpg" loading="lazy" id="d33e1163" height="794" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of S@A-NPs in the brains of mice. (<strong>a</strong>) Schematic description of the timeline of experimental procedures. Adult mice were intravenously injected with free SIM or S@A-NPs for one time. (<strong>b</strong>) The brain uptake kinetics of SIM (concentration in µg g<sup>− 1</sup> brain tissue) were measured at various time points following a single injection. (<strong>c</strong>) Schematic description of the timeline of experimental procedures. Adult mice were intravenously injected with free SIM or S@A-NPs for seven consecutive times at a frequency once per one or two days. (<strong>d</strong>) The brain uptake kinetics of SIM (concentration in µg g<sup>− 1</sup> brain tissue) were measured at various time points following multiple injection. (<strong>e</strong>) Schematic description of the timeline of experimental procedures. Adult mice were intravenously injected with CY3-conjugated S@A-NPs for two consecutive times at a frequency once per 12 h. (<strong>f</strong>) Distribution of CY3<sup>+</sup> signals in the brain of CY3-conjugated S@A-NPs-administered mice. (<strong>g</strong>) The coronal sections of hippocampus of CY3-conjugated S@A-NPs-administered mice were immunostained for CD31, NeuN, GFAP or IBA-1 and DAPI. (<strong>h</strong>) The coronal brain sections were immunostained for CD31, PDGFR<em>β</em>, and DAPI in the hippocampus. Smooth endothelial cells and pericytes with nuclei were indicated by arrowheads and arrows, respectively. (<strong>i</strong>) Percentage of CY3<sup>+</sup> marker<sup>+</sup> cells among total marker<sup>+</sup> cells in the brains. Data are presented as mean ± SEM. <em>n</em> = 5 mice (b, d), <em>n</em> = 7–13 slices from 3 mice/group (i). *<em>p</em> &lt; 0.05. **<em>p</em> &lt; 0.01. Student t-test. Scale bars: 1 mm (f), 20 μm (g), 10 μm (h)</p></figcaption></figure><p id="Par33">We further analyzed the distribution of S@A-NPs in the brain parenchyma of the adult mice following IV administration of CY3-conjugated S@A-NPs (Fig. <a href="#Fig2" class="usa-link">2</a>e-f). Immunofluorescence staining for markers of distinct cell types was performed 24 h post-injection. The results showed that the CY3<sup>+</sup> cells were predominantly endothelial cells (CD31<sup>+</sup>, 97.98%) (Fig. <a href="#Fig2" class="usa-link">2</a>g, i). Only a small proportion of neurons (NeuN<sup>+</sup>, 2.02%) displayed CY3<sup>+</sup> signals, which localized primarily in the perirhinal cortex (Supplementary Fig. <a href="#MOESM1" class="usa-link">2</a>a). The density of CY3<sup>+</sup> nanoparticles in perirhinal cortical neurons was significantly lower than that in endothelial cells, indicating that while some perirhinal cortical neurons internalized the nanoparticles, the quantity of nanoparticles they absorbed was minimal (Supplementary Fig. <a href="#MOESM1" class="usa-link">2</a>a-b). Few CY3<sup>+</sup> neurons were observed in other brain regions. Furthermore, we did not detect CY3<sup>+</sup> signals in astrocytes (GFAP<sup>+</sup>), microglia (IBA-1<sup>+</sup>), or pericytes (PDGFR<em>β</em><sup>+</sup>) (Fig. <a href="#Fig2" class="usa-link">2</a>g-i). These results demonstrate that IV administered S@A-NPs were successfully internalized by endothelial cells.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Administration of S@A-NPs enhances endothelial LRP1 levels in the brain</h3>
<p id="Par34">The critical role of brain endothelial LRP1 in AD pathogenesis makes it an attractive therapeutic target for AD therapy. We previously reported that S@A-NPs could upregulate the expression of LRP1 in brain microvascular endothelial cells, thereby enhancing BBB targeting and facilitating the internalization of LRP1-targeted nanoparticles through a “self-promoting” mechanism in mouse model with brain metastases [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. To confirm this, we treated bEND.3 endothelial cells with free SIM and observed dose-dependent LRP1 upregulation. At the SIM concentrations of 1 µM (0.42 µg/mL), LRP1 expression significantly increased compared to untreated controls in bEND.3 cells (Supplementary Fig. <a href="#MOESM1" class="usa-link">3</a>a). The expression of LRP1 in bEND.3 cells treated with 1 µM S@A-NPs was comparable to that in cells treated with free SIM (Supplementary Fig. <a href="#MOESM1" class="usa-link">3</a>b). Notably, the blank A-NPs showed no effect on endothelial LRP1 expression level in vitro or in vivo (Supplementary Fig. <a href="#MOESM1" class="usa-link">3</a>b-d) [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>], further approving a capability of S@A-NPs via releasing SIM in upregulating LRP1 expression as described previously [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>].</p>
<p id="Par35">Consistent with the previous finding that S@A-NPs upregulate LRP1 expression by releasing SIM [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>], we further confirmed LRP1 expression in the brains of APP/PS1 mice treated with S@A-NPs. While no preclinical model fully recapitulates the complexity of human AD pathogenesis, the APP/PS1 transgenic mouse remains a scientifically validated and widely adopted system for studying early AD mechanisms. These mice exhibit well-characterized temporal pathology: amyloid plaques emerge in the cortex at about 4 months of age and ‌in‌ the hippocampus at about 6 months of age, increasing in density with aging‌ [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>];‌ ‌inflammatory responses increase‌ at 3 months ‌of age‌, ‌and significant memory deficits appear‌ at 5 months ‌of age [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>]‌. Crucially, BBB dysfunction, a key focus of this study, manifests at about 4 months of age [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>], preceding significant A<em>β</em> deposition. This model provides a rigorous platform for investigating the BBB-A<em>β</em> feedback loop central to AD pathological progression: BBB impairment accelerates A<em>β</em> accumulation, which further damages cerebrovascular integrity. We thus examined whether S@A-NPs could specifically target this early pathological cascade. Mice were intravenously injected with S@A-NPs for three months, starting at 5.5 months of age (Fig. <a href="#Fig3" class="usa-link">3</a>a). This treatment regimen targets the critical period of exacerbating pathology to evaluate the efficacy of earlier and sustained intervention. Western blot analysis showed elevated LRP1 levels in the cortex and hippocampus of S@A-NPs-treated APP/PS1 transgenic mice compared to saline-treated controls (Fig. <a href="#Fig3" class="usa-link">3</a>b-c). In contrast, there was no change in the expression of RAGE (Supplementary Fig. <a href="#MOESM1" class="usa-link">4</a>), another key transporter mediating A<em>β</em> influx across the BBB. As described previously, endothelial LRP1 expression is significantly reduced in the brains of AD animal models [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Paradoxically, upregulation of LRP1 in neurons facilitates the propagation of pathological tau [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Immunofluorescence analysis showed a loss of endothelial LRP1 and an upregulated neuronal LRP1 in the hippocampi of APP/PS1 mice compared to WT mice, which was attenuated by S@A-NPs treatment (Fig. <a href="#Fig3" class="usa-link">3</a>d-f). Given IV delivered S@A-NPs are mainly distributed in endothelial cells rather than in hippocampal neurons, the observed reduction in neuronal LRP1 may result from crosstalk between endothelial cells and neurons [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a> − <a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Thus, these results indicate that IV delivered S@A-NPs distribute in brain endothelial cells and effectively enhance endothelial LRP1 expression level, thereby highlighting their potential therapeutic impact in AD.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/a457b74e78d7/13195_2025_1840_Fig3_HTML.jpg" loading="lazy" id="d33e1343" height="792" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs treatment enhances endothelial LRP1 expression level. (<strong>a</strong>) Schematic description of experimental timeline. APP/PS1 mice were intravenously injected with S@A-NPs at 5.5 months of age and subjected to behavioral tests and analysis of AD-related pathology at 7.5 and 8.5 months of age, respectively. (<strong>b</strong>, <strong>c</strong>) WB analysis of LRP1 levels in the cortex and hippocampus of APP/PS1 mice treated with either normal saline (Ctrl) or S@A-NPs. GAPDH was detected as a loading control. Relative levels of LRP1 were quantified. (<strong>d</strong>) The coronal hippocampal sections were immunostained for LRP1, DAPI and CD31or NeuN. (<strong>e</strong>-<strong>f</strong>) The LRP1<sup>+</sup> MFI of in hippocampal endothelial cells (<strong>e</strong>) or neurons (<strong>f</strong>). Data are presented as mean ± SEM. <em>n</em> = 6–7 mice/group (c), <em>n</em> = 3 mice/group (e, f), * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01; *** <em>p</em> &lt; 0.001. One-way ANOVA (c). Student t-test (e, f). Scale bars: 20 μm (d)</p></figcaption></figure></section><section id="Sec22"><h3 class="pmc_sec_title">Administration of S@A-NPs repairs the damaged BBB in APP/PS1 transgenic mice</h3>
<p id="Par37">Impaired BBB function is an earlier pathological event in AD, occurring even before the accumulation of A<em>β</em>. One mechanism underlying BBB dysfunction in AD is the loss of endothelial LRP1, which leads to a substantial reduction in tight junction proteins, including zonula occludens 1 (ZO-1), claudin-5, and occludin. Notably, previous studies have shown that endothelial delivery of LRP1 via AAVs can restore the tight junction proteins and improve the BBB integrity in mice with endothelial LRP1 deficiency [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Given the potent capability of S@A-NPs to upregulate endothelial LRP1, we investigated whether administration of S@A-NPs could benefit BBB integrity in APP/PS1 mice. Consistent with the loss of endothelial LRP1 in AD brains, APP/PS1 mice displayed a significant reduction in the tight junction protein levels (ZO-1, claudin-5, and occludin) compared to WT mice. However, these reductions were partially rescued by S@A-NPs (Fig. <a href="#Fig4" class="usa-link">4</a>a-f). To further evaluate BBB integrity, we injected 10 kDa and 40 kDa FITC-conjugated dextran tracers into the tail veins of APP/PS1 mice and quantified their densities in the brain parenchyma. The results demonstrated impaired BBB integrity in APP/PS1 mice, as evidenced by increased tracer density in the brain parenchyma compared to WT mice. Importantly, administration of S@A-NPs partially rescued the BBB dysfunction (Fig. <a href="#Fig4" class="usa-link">4</a>g-i). These results suggest that specifically increasing endothelial LPR1 expression level alleviates BBB impairment in APP/PS1 mice by preventing the loss of the tight junction proteins, thereby enhancing BBB integrity.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/e97788317186/13195_2025_1840_Fig4_HTML.jpg" loading="lazy" id="d33e1437" height="1016" width="749" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs treatment ameliorates impairment in BBB of APP/PS1 transgenic mice. (<strong>a</strong>-<strong>f</strong>) Coronal hippocampal sections were immunostained for CD31 and ZO1 (<strong>a</strong>), Claudin 5 (<strong>b</strong>) or Occludin (<strong>c</strong>), and DAPI. Percentages of ZO1<sup>+</sup> (<strong>d</strong>), Claudin 5<sup>+</sup> (<strong>e</strong>), and Occludin<sup>+</sup> (<strong>f</strong>) area occupied in the total CD31<sup>+</sup> area. (<strong>g</strong>) Representative images in the cortex and hippocampus coronal sections assessed BBB leakage by 10 KDa and 40 KDa FITC-dextran. (<strong>h</strong>, <strong>i</strong>) Percentage of 10 KDa (h) or 40 KDa (i) FITC-dextran<sup>+</sup> areas in the cortex and hippocampus coronal sections. Data are presented as mean ± SEM. <em>n</em> = 13–15 slices from 3 mice/group (d, e); <em>n</em> = 14–17 slices from 3 mice/group (f); <em>n</em> = 3 mice/group (h, i); * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01; *** <em>p</em> &lt; 0.001. One-way ANOVA (d-f, h, i). Scale bars: 20 μm (a, b, c); 500 and 100 μm in the images with lower and higher magnification, respectively (g)</p></figcaption></figure></section><section id="Sec23"><h3 class="pmc_sec_title">Administration of S@A-NPs ameliorates A<em>β</em> accumulation in APP/PS1 transgenic mice</h3>
<p id="Par39">In addition to preserving BBB integrity, endothelial LRP1 plays a critical role in regulating A<em>β</em> clearance and accumulation [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. To evaluate whether administration of S@A-NPs could alleviate AD pathology, we analyzed A<em>β</em> accumulation in APP/PS1 mice. These mice begin to exhibit A<em>β</em> plaques as early as 3 months of age, followed by neurodegeneration and cognitive deficits by 7 months of age [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Starting at 5.5 months of age, when A<em>β</em> accumulation, neuroinflammation, and neurodegeneration are already present, APP/PS1 mice were intravenously injected with S@A-NPs for 3 months at a frequency of once every two weeks (Fig. <a href="#Fig3" class="usa-link">3</a>a). Immunofluorescence staining using the 6E10 antibody revealed that the density of A<em>β</em> plaques in the hippocampus and cortex, measured by both the number and covered area of A<em>β</em> plaques, was significantly reduced in S@A-NPs-treated mice compared to saline-treated mice (Fig. <a href="#Fig5" class="usa-link">5</a>a-c). ELISA analysis showed that the levels of soluble A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> in the cortex of APP/PS mice were decreased following administration of S@A-NPs (Fig. <a href="#Fig5" class="usa-link">5</a>d, e). In the hippocampus, S@A-NPs treatment reduced soluble A<em>β</em><sub>40</sub> levels but had no significant effect on soluble A<em>β</em><sub>42</sub> levels (Fig. <a href="#Fig5" class="usa-link">5</a>f, g). This discrepancy could be attributed to the differential distribution of S@A-NPs across different brain regions. In contrast to the reduction of soluble A<em>β</em>, the insoluble A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> levels in the cortex and hippocampus were not decreased by S@A-NPs treatment (Fig. <a href="#Fig5" class="usa-link">5</a>h-k). Interestingly, administration of S@A-NPs even increased levels of insoluble A<em>β</em>40 in the hippocampus (Fig. <a href="#Fig5" class="usa-link">5</a>k). LRP1 exhibits a significantly higher affinity for A<em>β</em>40 compared to A<em>β</em>42, with reported transport efficiencies exceeding twofold [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>, <a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. The increased insoluble A<em>β</em>40 in the hippocampus may represent a complementary response to the therapeutic enhancement of soluble A<em>β</em>40 clearance. One plausible explanation is that accelerated efflux of soluble A<em>β</em>40 could transiently alter the equilibrium between soluble and insoluble A<em>β</em> pools or influence aggregation kinetics, potentially leading to a measurable shift toward the insoluble fraction in this specific region. However, the precise mechanism underlying this specific increase in hippocampal insoluble A<em>β</em>40 requires further investigation. These findings indicate that specifically increasing endothelial LPR1 expression level effectively attenuates A<em>β</em> accumulation, with a more pronounced impact on reducing soluble A<em>β</em> levels than insoluble A<em>β</em>. This highlights the potential of S@A-NPs as a therapeutic strategy for targeting the soluble forms of A<em>β</em>, which are considered to play a more direct role in AD pathogenesis.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/5faed2ea2ca9/13195_2025_1840_Fig5_HTML.jpg" loading="lazy" id="d33e1654" height="543" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs treatment attenuates A<strong><em>β</em></strong> accumulation in the brains of APP/PS1 transgenic mice. (<strong>a</strong>-<strong>c</strong>) Coronal brain sections were immunostained for A<em>β</em> and DAPI. Representative images in the cortex and hippocampus were shown. The number and covered area of A<em>β</em> plaques in the cortex and hippocampus coronal sections (<strong>b</strong>, <strong>c</strong>). (<strong>d</strong>-<strong>k</strong>) ELISA analysis of the soluble (<strong>d</strong>-<strong>g</strong>) and insoluble (<strong>h</strong>-<strong>k</strong>) A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> levels in the cortex and hippocampus. Data are presented as mean ± SEM. <em>n</em> = 17–19 slices from 3 mice/group for A<em>β</em> plaques analysis; <em>n</em> = 3–7 mice/group for ELISA analysis. * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01; *** <em>p</em> &lt; 0.001. Student t-test (<strong>b</strong>, <strong>c</strong>). One-way ANOVA (<strong>d</strong>-<strong>k</strong>). Scale bars: 500 μm and 50 μm, respectively, in the images with lower and higher magnification</p></figcaption></figure></section><section id="Sec24"><h3 class="pmc_sec_title">Administration of S@A-NPs enhances A<em>β</em> clearance while suppressing A<em>β</em> production</h3>
<p id="Par41">A<em>β</em> accumulation in AD is driven by both increased production and impaired clearance of A<em>β</em>. Given the critical role of endothelial LRP1 in facilitating A<em>β</em> transcytosis out of the brain [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], we investigated whether administration of S@A-NPs could modulate this process. To assess A<em>β</em> clearance, we prepared A<em>β</em> oligomers and injected SF555-conjugated A<em>β</em> oligomers into the hippocampal DG of 6-month-old APP/PS1 mice (Supplementary Fig. <a href="#MOESM1" class="usa-link">5</a>). The mice were IV administered with either S@A-NPs or NS for one month, and the levels of SF555-conjugated A<em>β</em> in the brains were analyzed 48 h post-injection (Fig. <a href="#Fig6" class="usa-link">6</a>a). Results showed that administration of S@A-NPs significantly reduced the levels of SF555-conjugated A<em>β</em> remnants in the brains of APP/PS1 mice (Fig. <a href="#Fig6" class="usa-link">6</a>b, c). Correspondingly, plasma levels of A<em>β</em><sub>42</sub> and A<em>β</em><sub>40</sub> were increased in S@A-NPs-treated mice, indicating an enhanced A<em>β</em> clearance via transcytosis into the bloodstream (Fig. <a href="#Fig6" class="usa-link">6</a>d, e). These results indicate that specifically increasing endothelial LPR1 expression level promotes A<em>β</em> clearance by accelerating its transcytosis across the BBB into the systemic circulation.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/078049f501ce/13195_2025_1840_Fig6_HTML.jpg" loading="lazy" id="d33e1848" height="691" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs treatment suppresses amyloidogenic cleavage of APP, while enhancing transcytosis of A <strong><em>β</em></strong>
<strong>out of the brains of APP/PS1 transgenic mice</strong>. (<strong>a</strong>) Schematic description of experimental timeline. APP/PS1 mice were intravenously injected with S@A-NPs at 6 months of age and subjected to analysis of A<em>β</em> clearance at 7 months of age. SF555-conjugated A<em>β</em> oligomers were stereotactically injected into the hippocampal DG. (<strong>b</strong>, <strong>c</strong>) SF555-conjugated A<em>β</em> remnants in the brains were shown 48 h after injection. Area of SF555-conjugated A<em>β</em> oligomers occupied in the hippocampal DG (<strong>c</strong>). (<strong>d</strong>, <strong>e</strong>) ELISA analysis of A<em>β</em><sub>42</sub> (<strong>d</strong>) and A<em>β</em><sub>40</sub> (<strong>e</strong>) levels in the plasma. (<strong>f</strong>) WB analysis of levels of full-length APP, BACE1 and <em>α</em>/<em>β</em>-CTF in the cortex and hippocampus. GAPDH was detected as a loading control. Relative levels of full-length APP (<strong>f</strong>, <strong>g</strong>), BACE1 (<strong>f</strong>, <strong>h</strong>), <em>β</em>-CTF (<strong>f</strong>, <strong>i</strong>), and <em>α</em>-CTF (<strong>f</strong>, <strong>j</strong>). Data are presented as mean ± SEM. <em>n</em> = 3 mice/group (c); <em>n</em> = 7–9 mice/group (d); <em>n</em> = 6–11 mice/group (e); <em>n</em> = 3–8 mice/group (g-j). * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01; *** <em>p</em> &lt; 0.001. One-way ANOVA (c-e, g-j). Scale bars: 100 μm (b)</p></figcaption></figure><p id="Par43">A<em>β</em> is generated by the sequential cleavage of APP by <em>β</em>-secretase (<em>β</em>-APP-cleaving enzyme-1, BACE1) and γ-secretase, a process referred to as the amyloidogenic pathway. In contrast, the cleavage of APP by <em>α</em>-secretase and γ-secretase, known as the non-amyloidogenic pathway, prevents A<em>β</em> generation since the cleavage site of APP by <em>α</em>-secretase is within the A<em>β</em> region [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. To examine whether S@A-NPs treatment affects these two pathways, we analyzed the levels of key proteins in these pathways by western blotting. Compared to control APP/PS1 mice, S@A-NPs-administered APP/PS1 exhibited decreased levels of APP and <em>β</em>-CTFs (APP fragments generated by BACE1 cleavage), in both the cortex and the hippocampus, while reduced BACE1 levels in the cortex but not in the hippocampus (Fig. <a href="#Fig6" class="usa-link">6</a>f-i). The decreased levels of <em>α</em>-CTF were observed in the cortex, but not in the hippocampus, likely due to the reduction of full-length APP (Fig. <a href="#Fig6" class="usa-link">6</a>f, j). In contrast, S@A-NPs treatment failed to alter the levels of the above proteins, except for BACE1, in the brains of WT mice (Fig. <a href="#Fig6" class="usa-link">6</a>f-j). BACE1 is significantly upregulated in brain endothelial cells and neurons of AD mouse models, leading to excessive production of neurotoxic A<em>β</em> peptides [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>, <a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. Consistently, we observed APP/PS1 mice exhibit increased BACE1 expression in both brain endothelial cells and neurons, compared to WT mice. S@A-NPs treatment decreases BACE1 levels in both endothelial cells and neurons within the cortex of APP/PS1 mice (Supplementary Fig. <a href="#MOESM1" class="usa-link">6</a>), contrasting with the primarily endothelial distribution of the nanocarriers themselves (Fig. <a href="#Fig2" class="usa-link">2</a>g-i). The downregulation of endothelial BACE1 is likely attributable to accelerated BACE1 turnover mediated by selective S@A-NP-induced upregulation of endothelial LRP1, which is known to inhibit BACE1-mediated APP cleavage and promote BACE1 degradation [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. While neuronal LRP1 expression is decreased (Fig. <a href="#Fig3" class="usa-link">3</a>d, f), neuronal BACE1 levels were nonetheless reduced by S@A-NPs treatment (Supplementary Fig. <a href="#MOESM1" class="usa-link">6</a>). We hypothesize that this neuronal BACE1 downregulation may result from the attenuation of cellular stresses, such as A<em>β</em> accumulation and neurodegeneration, induced by the treatment, as BACE1 expression is responsive to various stressors, including A<em>β</em> accumulation [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>, <a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>], hypoxia, and neuronal injury [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. These findings suggest that the effects of S@A-NPs on APP processing are context-dependent, occurring specifically under pathological conditions.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Administration of S@A-NPs attenuates neuroinflammation and neurodegeneration in APP/PS1 transgenic mice</h3>
<p id="Par44">Excessive neuroinflammation is an essential contributor to the pathological mechanisms of Alzheimer’s disease. Astrocytes and microglia, the primary immune cells in the central nervous system, become activated in response to A<em>β</em> plaques. Upon activation, these cells proliferate and accumulate around A<em>β</em> plaques, further contributing to neuroinflammation [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>, <a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]. To assess whether S@A-NPs treatment alleviates neuroinflammation in APP/PS1 mice, we examined astrocyte and microglia activation in the cortex and hippocampus. The results showed that the density of astrocytes and microglia, as reflected by the area covered by GFAP<sup>+</sup> (a marker for astrocytes, Fig. <a href="#Fig7" class="usa-link">7</a>a, c) and IBA-1<sup>+</sup> (a marker for microglia, Fig. <a href="#Fig7" class="usa-link">7</a>b, d) cells, decreased in both the cortex and hippocampus of S@A-NPs-treated APP/PS1 transgenic mice, compared to control APP/PS1 transgenic mice. Activated microglia and reactive astrocytes play a crucial role in neuroinflammation by secreting inflammatory factors [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. The transcript levels <em>of TNF-α</em>, <em>IL-1β</em>, <em>IL-6</em>, and <em>iNOS</em> in the brains of S@A-NPs-treated APP/PS1 transgenic mice also decreased significantly, compared to control APP/PS1 transgenic mice (Fig. <a href="#Fig7" class="usa-link">7</a>e). These results indicate that S@A-NP-mediated restoration of BBB integrity via endothelial LRP1 upregulation suppresses neuroinflammation by reducing activation of astrocytes and microglia and secretion of inflammatory factors.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/333d7ebf9263/13195_2025_1840_Fig7_HTML.jpg" loading="lazy" id="d33e2051" height="806" width="669" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs treatment attenuates neuroinflammation and neurodegeneration in the brains of APP/PS1 transgenic mice. The coronal sections of the cortex and hippocampus were immunostained for GFAP (<strong>a</strong>), IBA-1(<strong>b</strong>), synaptophysin (f, SYN), and DAPI. The percentage of the covered area of astrocytes (<strong>c</strong>) or microglia (<strong>d</strong>) occupied in the total area in the cortex and hippocampus coronal sections was quantified. (<strong>e</strong>) The relatively mRNA levels of <em>TNF-α</em>, <em>IL-1β</em>, <em>IL-6</em> and <em>iNOS</em> in the brains. (<strong>f</strong>) The hippocampal CA3 of mice were immunostained for SYN. Representative images. (<strong>g</strong>) The SYN<sup>+</sup> MFI in the hippocampal CA3 were quantified. &gt;Data are presented as mean ± SEM. <em>n</em> = 18–19 slices from 3 mice/group (c, d); <em>n</em> = 3–4 mice/group (e). <em>n</em> = 14–17 slices from 3 mice/group (<strong>g</strong>). *<em>p</em> &lt; 0.05; **<em>p</em> &lt; 0.01; *** <em>p</em> &lt; 0.001. Student t-test (c-e). One-way ANOVA (g). Scale bars: 200 and 50 μm in the images with lower and higher magnification, respectively (a, b); 50 μm (f)</p></figcaption></figure><p id="Par46">Synaptic loss is closely related to the cognitive dysfunction of AD [<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]. Synaptophysin, an integral membrane glycoprotein in presynaptic vesicles, serves as a reliable marker for quantifying synapse numbers. To assess the effect of S@A-NPs on synaptic preservation, we examined synaptic density by measuring the synaptophysin signals<sup>+</sup> in the hippocampal CA3 region, an area enriched in synapses. The results showed that S@A-NPs-administered APP/PS1 transgenic mice exhibited increased synaptic density compared to control APP/PS1 mice but decreased synaptic density compared to WT mice (Fig. <a href="#Fig7" class="usa-link">7</a>f-g). These results indicate that specifically increasing endothelial LPR1 expression level partially rescues synaptic loss in APP/PS1 mice, providing a potential mechanism for improving cognitive function in AD models.</p></section><section id="Sec26"><h3 class="pmc_sec_title">Administration of S@A-NPs rescues cognitive deficits of APP/PS1 transgenic mice</h3>
<p id="Par47">In summary, administration of S@A-NPs enhances BBB integrity by specifically upregulating the expression of endothelial LRP1 and alleviates A<em>β</em> accumulation, neurodegeneration, and neuroinflammation in APP/PS1 transgenic mice. We next examined whether administration of S@A-NPs could rescue the cognitive deficits in these mice. As described previously, APP/PS1 transgenic mice were intravenously injected with S@A-NPs at 5.5 months of age and subjected to behavioral tests two months after injection. The open field test showed that the S@A-NPs treatment did not affect the spontaneous locomotor function of the mice (Supplementary Fig. <a href="#MOESM1" class="usa-link">7</a>).</p>
<p id="Par48">The NOR test was used to assess declarative memory [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>]. The tested mice were initially habituated to two objects, with one replaced by a novel object 90 min later. However, cognitively impaired mice fail to remember the old object and show a reduced recognition index. APP/PS1 mice exhibited a reduced recognition index compared to WT mice, and this reduction was rescued by S@A-NPs treatment (Fig. <a href="#Fig8" class="usa-link">8</a>a, c). Furthermore, the preference index, which reflects the mice’s preference for the original objects, remained identical among groups of mice (Fig. <a href="#Fig8" class="usa-link">8</a>b), confirming the enhanced recognition index in S@A-NPs-treated APP/PS1 mice was due to the improved cognition, rather than a bias towards the objects themselves.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/e969b51249d7/13195_2025_1840_Fig8_HTML.jpg" loading="lazy" id="d33e2108" height="304" width="669" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>S@A-NPs rescues cognitive deficits of APP/PS1 transgenic mice. (<strong>a-c</strong>) Novel object recognition test. Schematic description of test design (a). preference index (b), and recognition index (c). (<strong>d-f</strong>) Object location recognition test. Schematic description of test design (d). preference index (e), and recognition index (f). Data are presented as mean ± SEM. <em>n</em> = 9–14 mice/group. * <em>p</em> &lt; 0.05; ** <em>p</em> &lt; 0.01. One-way ANOVA (b, c, e, f)</p></figcaption></figure><p id="Par50">The mice were subsequently subjected to the OLT test to assess spatial memory [<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. In the OLT test, the mice were first habituated to two identical objects placed in different locations during the training phase. 24 h later, one object was removed to a novel location (Fig. <a href="#Fig8" class="usa-link">8</a>e). Compared to WT mice, APP/PS1 mice showed a reduced recognition index in the OLT, and this impairment was rescued by S@A-NPs treatment (Fig. <a href="#Fig8" class="usa-link">8</a>f). Interestingly, S@A-NPs-treated WT mice exhibited similar recognition index levels in both the NOR and OLT tests (Fig. <a href="#Fig8" class="usa-link">8</a>c, f), suggesting that these nanoparticles do not affect the cognition of normal mice. Thus, these results indicate that specifically increasing endothelial LPR1 expression level rescues the cognitive deficits of APP/PS1 mice.</p></section></section><section id="Sec27"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par51">In this study, we demonstrate that S@A-NPs, LRP1-targeted nanoparticles, are internalized by endothelial cells after IV delivery, where they increase endothelial LRP1 expression through local SIM release. We further show that endothelial delivery of S@A-NPs improves BBB integrity, suppresses amyloidogenic cleavage of APP, enhances transcytosis of A<em>β</em> out of the brain, reduces neuroinflammation and neurodegeneration, and ultimately rescues cognitive deficits in an AD mouse model (Fig. <a href="#Fig9" class="usa-link">9</a>). Therefore, this study proposes the endothelial delivery of SIM as a novel potential therapeutic approach for AD. S@A-NPs rely on the binding of Angiopep-2 to endothelial LRP1 to facilitate their endocytosis by brain endothelial cells. Once internalized, S@A-NPs release SIM locally, which further upregulates endothelial the LRP1 expression. This, in turn, enhances the internalization of additional S@A-NPs, creating a self-amplifying feedback loop that results in the accumulation of SIM within endothelial cells [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. We propose that this “self-promoting” feedback mechanism, formed by endothelial LRP1 and S@A-NPs, is key to the selective distribution of S@A-NPs to brain endothelial cells and the upregulation of endothelial LRP1. In this context, the loss of endothelial LRP1 is an earlier biomarker and causative factor for aging [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>] and AD [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>] pathogenesis, as it is essential for BBB integrity [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>] and A<em>β</em> efflux [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>] from the brain. Consistent with this, our study demonstrates that S@A-NPs repair the damaged BBB and enhance A<em>β</em> transcytosis for peripheral clearance.</p>
<figure class="fig xbox font-sm" id="Fig9"><h3 class="obj_head">Fig. 9.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366182_13195_2025_1840_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc02/12366182/88a30bc91ffa/13195_2025_1840_Fig9_HTML.jpg" loading="lazy" id="d33e2183" height="608" width="669" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Administration of S@A-NPs attenuates AD pathogenesis by specifically upregulating endothelial LPR1 expression level. The loss of endothelial LRP1 impairs BBB and transcytosis of A<em>β</em>, resulting in A<em>β</em> accumulation, neuroinflammation, neurodegeneration, and cognitive deficits. Administration of S@A-NPs penetrates the brain across BBB, predominately distributed in the endothelial cells. S@A-NPs are internalized by endothelial cells and retained within the endothelial cells. S@A-NPs release SIM locally in the endothelial cells, upregulating the endothelial LRP1 levels. The latter repairs the damaged BBB, promoting the efflux of A<em>β</em>. In addition, administration of S@A-NPs decreases neuronal LRP1, possibly involving interaction between endothelial cells and neurons, suppressing A<em>β</em> production. Through these mechanisms, S@A-NPs attenuate A<em>β</em> accumulation, neuroinflammation, and neurodegeneration, eventually protecting the cognitive function of AD. The diagram created with BioRender.com and released under a Creative Commons Attribution-Non-Commercial NoDerivs 4.0 International license</p></figcaption></figure><p id="Par53">Surprisingly, while endothelial LRP1 level was upregulated, neuronal LRP1 level was decreased following administration of S@A-NPs. This suggests that after uptake by endothelial cells, SIM is locally released and not further taken up by other cell types. Given that S@A-NPs primarily target brain endothelial cells, the reduction of neuronal LRP1 may result from endothelial cells-neuronal crosstalk. Endothelial cells secrete factors involved in neuronal development [<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>, <a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>], myelination [<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>–<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>], and inflammation [<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>, <a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>], potentially explaining this phenomenon. However, further investigation is required to elucidate how endothelial-targeted S@A-NPs reduce neuronal LRP1 expression. It is noteworthy that, in contrast to endothelial LRP1, which is crucial for BBB integrity and A<em>β</em> transcytosis, neuronal LRP1 promotes A<em>β</em> production [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>–<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>] and tau propagation [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. In line with this, S@A-NPs treatment reduced amyloidogenic cleavage of APP. As amyloidogenic cleavage of APP predominantly occurs in neurons, where BACE1 is mainly expressed [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>], diminished neuronal LRP1 may contribute to S@A-NPs-mediated suppression of A<em>β</em> production. Additionally, decreased brain APP levels following S@A-NPs treatment may further reduce A<em>β</em> production. APP, a marker of axonal injury, is upregulated in damaged neurons [<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Thus, its downregulation may reflect attenuated neurodegeneration after S@A-NPs intervention. BACE1 is also expressed in endothelial cells, where it is predominantly localized abluminally [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. This localization enables cleavage of APP within endothelial cells, producing A<em>β</em> that directly contributes to cerebral amyloid deposition [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>, <a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]. Furthermore, endothelial BACE1 upregulation impairs BBB integrity independently of amyloidogenesis: it cleaves occludin, a tight junction protein, and reduces expression of ZO-1, JAM-A, and claudin-1 via cleavage-independent mechanisms [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]. We observed that S@A-NP treatment decreased endothelial BACE1 levels, potentially due to LRP1 upregulation promoting BACE1 degradation [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>, <a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. Stressors like A<em>β</em> accumulation [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>, <a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>], hypoxia, and neuronal injury [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>] also upregulate BACE1. Thus, S@A-NPs-mediated alleviation of A<em>β</em>-driven stress may contribute to endothelial BACE1 downregulation as well. Intriguingly, S@A-NPs reduced BACE1 levels in brain endothelial cells of APP/PS1 mice while increasing them in WT mice. We propose several non-exclusive mechanisms for this differential effect: (1) LRP1-mediated biodistribution differences: S@A-NPs rely on Angiopep-2 ligand binding to LRP1 for endothelial uptake. Differential endothelial LRP1 expression between AD transgenic mice and WT mice may drive distinct cellular responses to S@A-NPs; (2) Inherent context-dependent effects of simvastatin: Free SIM itself exhibits context-dependent effects. For example, it modulates cholesterol in dysregulated systems but exerts minimal change in normal mice [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>, <a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. S@A-NPs may thus act differentially based on baseline pathophysiology; (3) Stress-response modulation: In APP/PS1 mice, S@A-NPs-enhanced A<em>β</em> efflux alleviates A<em>β</em>-driven stress, thereby reducing BACE1 levels. This mechanism is likely inactive in A<em>β</em> pathology-free WT mice. Thus, the increased BACE expression in S@A-NPs-treated WT mice likely reflects the interplay of these mechanisms, particularly the absence of A<em>β</em> load attenuation and differential nanoparticle trafficking.</p>
<p id="Par54">Activation of astrocytes and microglia is a double-edged sword in AD pathogenesis. Their activation facilitates A<em>β</em> clearance at the earlier stage while accelerating neurodegeneration by inducing neuroinflammation in later stages. Astrocytes and microglia are recruited to amyloid plaques, where they proliferate and become activated [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>, <a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]. Thus, the reduced density of astrocytes and microglia observed in S@A-NPs-treated APP/PS1 mice may be attributed to decreased A<em>β</em> accumulation. However, the crosstalk between endothelial cells and glial cells may also contribute to the suppression of neuroinflammation resulting from the endothelial delivery of S@A-NPs [<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>–<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]. Further investigation is needed to understand the underlying mechanisms of the therapeutic effects of S@A-NPs.</p>
<p id="Par55">Administration of S@A-NPs reduced the accumulation of soluble, rather than insoluble, A<em>β</em> aggregates in the brain. This aligns with the observation that the APP/PS1 mice injected with S@A-NPs at 5.5 months of age had already accumulated A<em>β</em> plaques [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. The aggregation of A<em>β</em> impairs its clearance by endothelial cells. Earlier intervention, such as at 3 months of age in APP/PS1 mice when A<em>β</em> begins to accumulate, might be more effective in reducing insoluble A<em>β</em> aggregates. Similarly, the effects of S@A-NPs administration may be partially, but not entirely, due to the impaired BBB integrity and the neurodegeneration in APP/PS1 mice. Despite these observations, administration of S@A-NPs ultimately rescued cognitive deficits in APP/PS1 mice. This suggests that the partial recovery of BBB integrity and mitigation of neurodegeneration are sufficient to enhance functional cognition.</p>
<p id="Par56">While SIM is clinically recognized for its lipid-lowering effects, it prevents cholesterol elevation in hypercholesterolemic models but induces no significant change in total serum cholesterol in normal mice [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>, <a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]. Crucially, in the APP/PS1 mice used in this study, serum cholesterol levels remain comparable to those of wild-type littermates until advanced ages (e.g., 12 months) [<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>, <a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>], indicating minimal baseline dysregulation of serum cholesterol at our experimental timepoints. Consistent with this profile, our prior work demonstrated that sustained IV administration of S@A-NPs, despite delivering therapeutic SIM doses, did not alter systemic cholesterol levels in healthy mice [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. This can be attributed to the nanoparticles’ sustained-release profile and targeted biodistribution, which minimizes peripheral SIM exposure while concentrating therapeutic effects at the cerebrovascular endothelium. Importantly, this absence of systemic metabolic disruption confirms the safety profile of our approach and demonstrates that the observed endothelial LRP1 upregulation and BBB repair occur independently of whole-body cholesterol modulation. In this context, we demonstrated that long-term S@A-NPs treatment did not affect spontaneous locomotor activity, suggesting that such treatment does not cause myotoxicity, a common side effect associated with free SIM administration [<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]. Our prior study demonstrated that an identical S@A-NPs treatment improves survival in metastasis-bearing mice without observable toxicity, achieving efficacy comparable to doxorubicin chemotherapy [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. These data suggest the biosafety of S@A-NPs. However, further detailed histopathological evaluation of the biosafety of S@A-NPs is still required for IND-enabling studies.</p>
<p id="Par57">The loss of LRP1 is a well-established driver of BBB dysfunction in aging and AD [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>–<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>–<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>], positioning its restoration as a strategic therapeutic intervention. SIM, however, exhibited limited efficacy in AD therapy and caused adverse effects during long-term therapeutic use for AD [<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>, <a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>]. These effects may be linked to its role in upregulating neuronal LRP1 expression. Here, we demonstrate that S@A-NPs selectively localize to brain endothelial cells and actively repair BBB impairment in an AD model via targeted upregulation of endothelial LRP1. In this context, the present study represents a strategic and technical advance: First, unlike viral vector approaches, e.g., AAV-mediated LRP1 delivery [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>], which face translational safety barriers, S@A-NPs leverage clinically validated components: biodegradable PLGA polymer and SIM, both with decades-long safety records. Second, this study focuses on BBB breakdown, an early pathological event that accelerates A<em>β</em> deposition, neuroinflammation, and cognitive decline, thereby offering a potential opportunity for earlier intervention in disease modification. Third, and most significantly, while our previous study demonstrated the utility of S@A-NPs in improving drug distribution and survival outcomes in metastatic models, it did not explore the intrinsic biological activity of the S@A-NPs (devoid of drug cargo) on BBB integrity, a gap this study decisively addresses [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. This novel study found that the S@A-NPs themselves function therapeutically without requiring further loading with any drug, thereby attenuating AD pathogenesis.</p>
<p id="Par58">LRP1 is also expressed by hepatocytes. Thus, it is possible that S@A-NPs were uptaken by hepatocytes as well. However, due to the different cellular responses between endothelial cells and hepatocytes, further investigation is needed to determine whether S@A-NPs also enhance hepatocytic LRP1 expression. In this context, we emphasize the cell-type-specific functions of LRP1: brain endothelial cells employ LRP1 for A<em>β</em> transcytosis out of the CNS, while hepatocytes utilize it for systemic A<em>β</em> clearance from circulation [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>]. Thus, while S@A-NPs may interact with hepatocytes, their therapeutic effect on BBB repair stems principally from endothelial-specific LRP1 upregulation rather than hepatic modulation. Nevertheless, this study requires multiple IV injections of S@A-NPs, which may limit its clinical appeal. As a proof-of-concept study, our primary aim was to establish the therapeutic potential and mechanism of S@A-NPs. Future work will focus on optimizing nanoparticle design or exploring alternative delivery strategies (e.g., implantable devices) to reduce dosing frequency and enhance translational potential.</p></section><section id="Sec28"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366182/bin/13195_2025_1840_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (8.7MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12366182/bin/13195_2025_1840_MOESM2_ESM.xls" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (95KB, xls) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank all the members of Quan-Hong Ma’s laboratory for the discussions and suggestions.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>AD</dt>
<dd><p id="Par62">Alzheimer’s disease</p></dd>
<dt>APP/PS1</dt>
<dd><p id="Par63">APPswe/PS1DE9</p></dd>
<dt>WT</dt>
<dd><p id="Par64">Wild-type</p></dd>
<dt>Aβ</dt>
<dd><p id="Par65">Amyloid β</p></dd>
<dt>BBB</dt>
<dd><p id="Par66">Blood brain barrier</p></dd>
<dt>SIM</dt>
<dd><p id="Par67">Simvastatin</p></dd>
<dt>NS</dt>
<dd><p id="Par68">Normal saline</p></dd>
<dt>NPs</dt>
<dd><p id="Par69">Nanoparticles</p></dd>
<dt>HMG-CoA</dt>
<dd><p id="Par70">Hydroxy methylglutaryl-coenzyme A</p></dd>
<dt>LRP1</dt>
<dd><p id="Par71">Low-density lipoprotein receptor related protein 1</p></dd>
<dt>RAGE</dt>
<dd><p id="Par72">Receptor for advanced glycation end-products</p></dd>
<dt>ZO1</dt>
<dd><p id="Par73">Zona occludens 1</p></dd>
<dt>CBF</dt>
<dd><p id="Par74">cerebral blood flow</p></dd>
<dt>BACE1</dt>
<dd><p id="Par75">β-site APP cleaving enzyme 1</p></dd>
<dt>CTF</dt>
<dd><p id="Par76">C-terminal fragment.</p></dd>
<dt>Cy3</dt>
<dd><p id="Par77">Cyanine 3 phosphoramidite</p></dd>
<dt>PLGA</dt>
<dd><p id="Par78">Polylactic-co-glycolic acid</p></dd>
<dt>PLL</dt>
<dd><p id="Par79">Poly-L-lysine</p></dd>
<dt>PEG</dt>
<dd><p id="Par80">Polyethylene glycol</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization, Q-H.M.; methodology, T-T.P. and Y-Y.S.; validation, Y-F.S., M.Z. and W-L.J.; formal analysis, T-T.P. and Y-F.S.; investigation, T-T.P., Y-Y.S., Y-F.S., M.Z., H-Y.C., W-L.J. and N-U.K.; resources, Q-H.M. and L.H.; data curation, T-T.P. and Y-Y.S.; writing-original draft preparation, Q-H.M.; T-T.P.; writing-review and editing, Y-Y.S., J.L., L.H., and Q-H.M.; supervision, Q-H.M.; funding acquisition, Q-H.M., Y-Y.S. and L.H.; All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The authors are grateful to the following funds for support: the STI2030-Major Projects (2021ZD0204001), the National Natural Science Foundation of China (92049120, 81870897), Sino German cooperation and exchange project (M-0679), the Project of MOE Key Laboratory of Geriatric Diseases and Immunology (A0103), the Guangdong Key Project in the Development of New Tools for the Diagnosis and Treatment of Autism (2018B030335001), Research Project of Neurological Diseases in the Second Affiliated Hospital of Suzhou University, Research Center (ND2024A01), the Basic Frontier Innovation Cross-Scientific Research Project of Suzhou Medical College of Soochow University (YXY2304058), Suzhou International Joint Laboratory for Diagnosis and Treatment of Brain Diseases, A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, National Natural Science Foundation of China (32171381), and Natural Science Foundation of Jiangsu Province (BK20240149).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The data that supports the conclusions of this study are available in the paper and/or the Supplementary material.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar3"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par59">All procedures were approved by the Institutional Animal Care and Use Committee of Soochow University and were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals guidelines for the ethical treatment of animals. Efforts were made to minimize the number of animals used.</p></section><section id="FPar1"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par60">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par61">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Ting-Ting Pan and Yan-Yun Sun contributed equally.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Liang Han, Email: hanliang@suda.edu.cn.</p>
<p>Quan-Hong Ma, Email: maquanhong@suda.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Gulisano W, Maugeri D, Baltrons M A, et al. Role of amyloid-beta and Tau proteins in alzheimer’s disease: confuting the amyloid cascade [J]. J Alzheimers Dis. 2018;64(s1):S611–31.
</cite> [<a href="https://doi.org/10.3233/JAD-179935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8371153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29865055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gulisano%20W,%20Maugeri%20D,%20Baltrons%20M%20A,%20et%20al.%20Role%20of%20amyloid-beta%20and%20Tau%20proteins%20in%20alzheimer%E2%80%99s%20disease:%20confuting%20the%20amyloid%20cascade%20%5BJ%5D.%20J%20Alzheimers%20Dis.%202018;64(s1):S611%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Gallego-Rudolf J, Wiesman A I, Pichet Binette A, et al. Synergistic association of Abeta and Tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults [J]. Nat Neurosci. 2024;27(11):2130–7.
</cite> [<a href="https://doi.org/10.1038/s41593-024-01763-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11537964/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39294489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gallego-Rudolf%20J,%20Wiesman%20A%20I,%20Pichet%20Binette%20A,%20et%20al.%20Synergistic%20association%20of%20Abeta%20and%20Tau%20pathology%20with%20cortical%20neurophysiology%20and%20cognitive%20decline%20in%20asymptomatic%20older%20adults%20%5BJ%5D.%20Nat%20Neurosci.%202024;27(11):2130%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Solis E JR, Hascup K N, Hascup ER. Alzheimer’s disease: the link between Amyloid-beta and neurovascular dysfunction [J]. J Alzheimers Dis. 2020;76(4):1179–98.
</cite> [<a href="https://doi.org/10.3233/JAD-200473" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7483596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32597813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Solis%20E%20JR,%20Hascup%20K%20N,%20Hascup%20ER.%20Alzheimer%E2%80%99s%20disease:%20the%20link%20between%20Amyloid-beta%20and%20neurovascular%20dysfunction%20%5BJ%5D.%20J%20Alzheimers%20Dis.%202020;76(4):1179%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Hampel H, Hardy J, Blennow K, et al. The Amyloid-β pathway in alzheimer’s disease [J]. Mol Psychiatry. 2021;26(10):5481–503.
</cite> [<a href="https://doi.org/10.1038/s41380-021-01249-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8758495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34456336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hampel%20H,%20Hardy%20J,%20Blennow%20K,%20et%20al.%20The%20Amyloid-%CE%B2%20pathway%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Mol%20Psychiatry.%202021;26(10):5481%E2%80%93503." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Li Y, Sun Z. Role of amyloid beta protein receptors in mediating synaptic plasticity [J]. Biomed Rep. 2017;6(4):379–86.
</cite> [<a href="https://doi.org/10.3892/br.2017.863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5374942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28413635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Sun%20Z.%20Role%20of%20amyloid%20beta%20protein%20receptors%20in%20mediating%20synaptic%20plasticity%20%5BJ%5D.%20Biomed%20Rep.%202017;6(4):379%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Liu L, Ding L, Rovere M, et al. A cellular complex of BACE1 and gamma-secretase sequentially generates Abeta from its full-length precursor [J]. J Cell Biol. 2019;218(2):644–63.
</cite> [<a href="https://doi.org/10.1083/jcb.201806205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6363461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30626721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20L,%20Ding%20L,%20Rovere%20M,%20et%20al.%20A%20cellular%20complex%20of%20BACE1%20and%20gamma-secretase%20sequentially%20generates%20Abeta%20from%20its%20full-length%20precursor%20%5BJ%5D.%20J%20Cell%20Biol.%202019;218(2):644%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Zhang X, Song W. The role of APP and BACE1 trafficking in APP processing and amyloid-beta generation [J]. Alzheimers Res Ther. 2013;5(5):46.
</cite> [<a href="https://doi.org/10.1186/alzrt211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3978418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24103387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20X,%20Song%20W.%20The%20role%20of%20APP%20and%20BACE1%20trafficking%20in%20APP%20processing%20and%20amyloid-beta%20generation%20%5BJ%5D.%20Alzheimers%20Res%20Ther.%202013;5(5):46." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Storck SE, Nahrath Meisters. Endothelial LRP1 transports amyloid-beta(1–42) across the blood-brain barrier [J]. J Clin Invest. 2016;126(1):123–36.
</cite> [<a href="https://doi.org/10.1172/JCI81108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4701557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26619118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Storck%20SE,%20Nahrath%20Meisters.%20Endothelial%20LRP1%20transports%20amyloid-beta(1%E2%80%9342)%20across%20the%20blood-brain%20barrier%20%5BJ%5D.%20J%20Clin%20Invest.%202016;126(1):123%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Deane R, Du Yan S, Submamaryan R K, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain [J]. Nat Med. 2003;9(7):907–13.
</cite> [<a href="https://doi.org/10.1038/nm890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12808450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deane%20R,%20Du%20Yan%20S,%20Submamaryan%20R%20K,%20et%20al.%20RAGE%20mediates%20amyloid-beta%20peptide%20transport%20across%20the%20blood-brain%20barrier%20and%20accumulation%20in%20brain%20%5BJ%5D.%20Nat%20Med.%202003;9(7):907%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Zhang W, Xiong H, Callaghan D, et al. Blood-brain barrier transport of amyloid beta peptides in efflux pump knock-out animals evaluated by in vivo optical imaging [J]. Fluids Barriers CNS. 2013;10(1):13.
</cite> [<a href="https://doi.org/10.1186/2045-8118-10-13" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3601014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23432917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20W,%20Xiong%20H,%20Callaghan%20D,%20et%20al.%20Blood-brain%20barrier%20transport%20of%20amyloid%20beta%20peptides%20in%20efflux%20pump%20knock-out%20animals%20evaluated%20by%20in%20vivo%20optical%20imaging%20%5BJ%5D.%20Fluids%20Barriers%20CNS.%202013;10(1):13." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Keaney J, Walsh D M, O’Malley T, et al. Autoregulated paracellular clearance of amyloid-beta across the blood-brain barrier [J]. Sci Adv. 2015;1(8):e1500472.
</cite> [<a href="https://doi.org/10.1126/sciadv.1500472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4610013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26491725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keaney%20J,%20Walsh%20D%20M,%20O%E2%80%99Malley%20T,%20et%20al.%20Autoregulated%20paracellular%20clearance%20of%20amyloid-beta%20across%20the%20blood-brain%20barrier%20%5BJ%5D.%20Sci%20Adv.%202015;1(8):e1500472." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Prakash P, Jethava K P, Korte N, et al. Monitoring phagocytic uptake of amyloid beta into glial cell lysosomes in real time [J]. Chem Sci. 2021;12(32):10901–18.
</cite> [<a href="https://doi.org/10.1039/d1sc03486c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8372545/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34476070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prakash%20P,%20Jethava%20K%20P,%20Korte%20N,%20et%20al.%20Monitoring%20phagocytic%20uptake%20of%20amyloid%20beta%20into%20glial%20cell%20lysosomes%20in%20real%20time%20%5BJ%5D.%20Chem%20Sci.%202021;12(32):10901%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Van Olst L, Edwards A J Simontonb et al. Microglial mechanisms drive amyloid-beta clearance in immunized patients with Alzheimer’s disease [J]. Nat Med, 2025;31(5):1604–16.</cite> [<a href="https://doi.org/10.1038/s41591-025-03574-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12092304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40050704/" class="usa-link">PubMed</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Feng W, Zhang Y, Wang Z, et al. Microglia prevent beta-amyloid plaque formation in the early stage of an alzheimer’s disease mouse model with suppression of glymphatic clearance [J]. Alzheimers Res Ther. 2020;12(1):125.
</cite> [<a href="https://doi.org/10.1186/s13195-020-00688-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7532614/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33008458/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feng%20W,%20Zhang%20Y,%20Wang%20Z,%20et%20al.%20Microglia%20prevent%20beta-amyloid%20plaque%20formation%20in%20the%20early%20stage%20of%20an%20alzheimer%E2%80%99s%20disease%20mouse%20model%20with%20suppression%20of%20glymphatic%20clearance%20%5BJ%5D.%20Alzheimers%20Res%20Ther.%202020;12(1):125." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Wu D, Chen Q, Chen X, et al. The blood-brain barrier: structure, regulation, and drug delivery [J]. Signal Transduct Target Ther. 2023;8(1):217.
</cite> [<a href="https://doi.org/10.1038/s41392-023-01481-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10212980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37231000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20D,%20Chen%20Q,%20Chen%20X,%20et%20al.%20The%20blood-brain%20barrier:%20structure,%20regulation,%20and%20drug%20delivery%20%5BJ%5D.%20Signal%20Transduct%20Target%20Ther.%202023;8(1):217." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Nation D A, Sweeney M D Montagnea, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction [J]. Nat Med. 2019;25(2):270–6.
</cite> [<a href="https://doi.org/10.1038/s41591-018-0297-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6367058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30643288/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nation%20D%20A,%20Sweeney%20M%20D%20Montagnea,%20et%20al.%20Blood-brain%20barrier%20breakdown%20is%20an%20early%20biomarker%20of%20human%20cognitive%20dysfunction%20%5BJ%5D.%20Nat%20Med.%202019;25(2):270%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Montagne A, Barnes S R, Sweeney M D, et al. Blood-brain barrier breakdown in the aging human hippocampus [J]. Neuron. 2015;85(2):296–302.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2014.12.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4350773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25611508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montagne%20A,%20Barnes%20S%20R,%20Sweeney%20M%20D,%20et%20al.%20Blood-brain%20barrier%20breakdown%20in%20the%20aging%20human%20hippocampus%20%5BJ%5D.%20Neuron.%202015;85(2):296%E2%80%93302." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Van De Haar H J, Jansen J F A, Van Osch M J P, et al. Neurovascular unit impairment in early alzheimer’s disease measured with magnetic resonance imaging [J]. Neurobiol Aging. 2016;45:190–6.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2016.06.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27459939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20De%20Haar%20H%20J,%20Jansen%20J%20F%20A,%20Van%20Osch%20M%20J%20P,%20et%20al.%20Neurovascular%20unit%20impairment%20in%20early%20alzheimer%E2%80%99s%20disease%20measured%20with%20magnetic%20resonance%20imaging%20%5BJ%5D.%20Neurobiol%20Aging.%202016;45:190%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Sweeney Md, Kisler K, Montagne A, et al. The role of brain vasculature in neurodegenerative disorders [J]. Nat Neurosci. 2018;21(10):1318–31.
</cite> [<a href="https://doi.org/10.1038/s41593-018-0234-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6198802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30250261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sweeney%20Md,%20Kisler%20K,%20Montagne%20A,%20et%20al.%20The%20role%20of%20brain%20vasculature%20in%20neurodegenerative%20disorders%20%5BJ%5D.%20Nat%20Neurosci.%202018;21(10):1318%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Weller R O Masseya, KUO Y M, et al. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in alzheimer’s disease [J]. Ann N Y Acad Sci. 2000;903:110–7.
</cite> [<a href="https://doi.org/10.1111/j.1749-6632.2000.tb06356.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10818495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weller%20R%20O%20Masseya,%20KUO%20Y%20M,%20et%20al.%20Cerebral%20amyloid%20angiopathy:%20accumulation%20of%20A%20beta%20in%20interstitial%20fluid%20drainage%20pathways%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Ann%20N%20Y%20Acad%20Sci.%202000;903:110%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>De Strooper B Karrane. The cellular phase of alzheimer’s disease [J]. Cell. 2016;164(4):603–15.
</cite> [<a href="https://doi.org/10.1016/j.cell.2015.12.056" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26871627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?De%20Strooper%20B%20Karrane.%20The%20cellular%20phase%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Cell.%202016;164(4):603%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Cheng Y, Tian D Y, Wang Y J. Peripheral clearance of brain-derived Abeta in alzheimer’s disease: pathophysiology and therapeutic perspectives [J]. Transl Neurodegener. 2020;9(1):16.
</cite> [<a href="https://doi.org/10.1186/s40035-020-00195-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7204069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32381118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20Y,%20Tian%20D%20Y,%20Wang%20Y%20J.%20Peripheral%20clearance%20of%20brain-derived%20Abeta%20in%20alzheimer%E2%80%99s%20disease:%20pathophysiology%20and%20therapeutic%20perspectives%20%5BJ%5D.%20Transl%20Neurodegener.%202020;9(1):16." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Xiang Y, Bu X L, Liu Y H, et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for alzheimer’s disease [J]. Acta Neuropathol. 2015;130(4):487–99.
</cite> [<a href="https://doi.org/10.1007/s00401-015-1477-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4575389/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26363791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiang%20Y,%20Bu%20X%20L,%20Liu%20Y%20H,%20et%20al.%20Physiological%20amyloid-beta%20clearance%20in%20the%20periphery%20and%20its%20therapeutic%20potential%20for%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Acta%20Neuropathol.%202015;130(4):487%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Zheng Z G, Xu Y Y, Liu W P et al. Discovery of a potent allosteric activator of DGKQ that ameliorates obesity-induced insulin resistance via the sn-1,2-DAG-PKCepsilon signaling axis [J]. Cell Metab, 2023;35(1): 101 – 17 e11.</cite> [<a href="https://doi.org/10.1016/j.cmet.2022.11.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36525963/" class="usa-link">PubMed</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Knox E G, Aburto M R, Clarke G, et al. The blood-brain barrier in aging and neurodegeneration [J]. Mol Psychiatry. 2022;27(6):2659–73.
</cite> [<a href="https://doi.org/10.1038/s41380-022-01511-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9156404/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35361905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Knox%20E%20G,%20Aburto%20M%20R,%20Clarke%20G,%20et%20al.%20The%20blood-brain%20barrier%20in%20aging%20and%20neurodegeneration%20%5BJ%5D.%20Mol%20Psychiatry.%202022;27(6):2659%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Tachibana M, Holm M L, LIU C C, et al. APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1 [J]. J Clin Invest. 2019;129(3):1272–7.
</cite> [<a href="https://doi.org/10.1172/JCI124853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6391135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30741718/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tachibana%20M,%20Holm%20M%20L,%20LIU%20C%20C,%20et%20al.%20APOE4-mediated%20amyloid-beta%20pathology%20depends%20on%20its%20neuronal%20receptor%20LRP1%20%5BJ%5D.%20J%20Clin%20Invest.%202019;129(3):1272%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Yamazaki Y, Zhao N. Apolipoprotein E and alzheimer disease: pathobiology and targeting strategies [J]. Nat Rev Neurol. 2019;15(9):501–18.
</cite> [<a href="https://doi.org/10.1038/s41582-019-0228-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7055192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31367008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yamazaki%20Y,%20Zhao%20N.%20Apolipoprotein%20E%20and%20alzheimer%20disease:%20pathobiology%20and%20targeting%20strategies%20%5BJ%5D.%20Nat%20Rev%20Neurol.%202019;15(9):501%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Storck S E Kurtykam, Pietrzik C U. Brain endothelial LRP1 maintains blood-brain barrier integrity [J]. Fluids Barriers CNS. 2021;18(1):27.
</cite> [<a href="https://doi.org/10.1186/s12987-021-00260-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8214794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34147102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Storck%20S%20E%20Kurtykam,%20Pietrzik%20C%20U.%20Brain%20endothelial%20LRP1%20maintains%20blood-brain%20barrier%20integrity%20%5BJ%5D.%20Fluids%20Barriers%20CNS.%202021;18(1):27." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Nikolakopoulou A M, Wang Y, Ma Q et al. Endothelial LRP1 protects against neurodegeneration by blocking Cyclophilin A [J]. J Exp Med, 2021;218(4).</cite> [<a href="https://doi.org/10.1084/jem.20202207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7863706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33533918/" class="usa-link">PubMed</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Shibata M, Yamada S, Kumar S R, et al. Clearance of alzheimer’s amyloid-ss(1–40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier [J]. J Clin Invest. 2000;106(12):1489–99.
</cite> [<a href="https://doi.org/10.1172/JCI10498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC387254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11120756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shibata%20M,%20Yamada%20S,%20Kumar%20S%20R,%20et%20al.%20Clearance%20of%20alzheimer%E2%80%99s%20amyloid-ss(1%E2%80%9340)%20peptide%20from%20brain%20by%20LDL%20receptor-related%20protein-1%20at%20the%20blood-brain%20barrier%20%5BJ%5D.%20J%20Clin%20Invest.%202000;106(12):1489%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Kanekiyo T, Liu C C, Shinohara M, et al. LRP1 in brain vascular smooth muscle cells mediates local clearance of alzheimer’s amyloid-beta [J]. J Neurosci. 2012;32(46):16458–65.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3987-12.2012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3508699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23152628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanekiyo%20T,%20Liu%20C%20C,%20Shinohara%20M,%20et%20al.%20LRP1%20in%20brain%20vascular%20smooth%20muscle%20cells%20mediates%20local%20clearance%20of%20alzheimer%E2%80%99s%20amyloid-beta%20%5BJ%5D.%20J%20Neurosci.%202012;32(46):16458%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Zhang Yl, Wang J, Zhang Z N, et al. The relationship between amyloid-beta and brain capillary endothelial cells in alzheimer’s disease [J]. Neural Regen Res. 2022;17(11):2355–63.
</cite> [<a href="https://doi.org/10.4103/1673-5374.335829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9120708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35535871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Yl,%20Wang%20J,%20Zhang%20Z%20N,%20et%20al.%20The%20relationship%20between%20amyloid-beta%20and%20brain%20capillary%20endothelial%20cells%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Neural%20Regen%20Res.%202022;17(11):2355%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Van Gool B, Storck S E, Reekmans S M, et al. LRP1 has a predominant role in production over clearance of Abeta in a mouse model of alzheimer’s disease [J]. Mol Neurobiol. 2019;56(10):7234–45.
</cite> [<a href="https://doi.org/10.1007/s12035-019-1594-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6728278/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31004319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Van%20Gool%20B,%20Storck%20S%20E,%20Reekmans%20S%20M,%20et%20al.%20LRP1%20has%20a%20predominant%20role%20in%20production%20over%20clearance%20of%20Abeta%20in%20a%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Mol%20Neurobiol.%202019;56(10):7234%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Wu T, Chen L, Zhou L, et al. Platelets transport beta-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of alzheimer’s disease in mouse models [J]. Aging. 2021;13(5):7644–59.
</cite> [<a href="https://doi.org/10.18632/aging.202662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7993748/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33668038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20T,%20Chen%20L,%20Zhou%20L,%20et%20al.%20Platelets%20transport%20beta-amyloid%20from%20the%20peripheral%20blood%20into%20the%20brain%20by%20destroying%20the%20blood-brain%20barrier%20to%20accelerate%20the%20process%20of%20alzheimer%E2%80%99s%20disease%20in%20mouse%20models%20%5BJ%5D.%20Aging.%202021;13(5):7644%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Bu X L, Xiang Y, Jin W S, et al. Blood-derived amyloid-beta protein induces alzheimer’s disease pathologies [J]. Mol Psychiatry. 2018;23(9):1948–56.
</cite> [<a href="https://doi.org/10.1038/mp.2017.204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29086767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bu%20X%20L,%20Xiang%20Y,%20Jin%20W%20S,%20et%20al.%20Blood-derived%20amyloid-beta%20protein%20induces%20alzheimer%E2%80%99s%20disease%20pathologies%20%5BJ%5D.%20Mol%20Psychiatry.%202018;23(9):1948%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Halliday M R, Rege S V Maq, et al. Accelerated pericyte degeneration and blood-brain barrier breakdown in Apolipoprotein E4 carriers with alzheimer’s disease [J]. J Cereb Blood Flow Metab. 2016;36(1):216–27.
</cite> [<a href="https://doi.org/10.1038/jcbfm.2015.44" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4758554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25757756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Halliday%20M%20R,%20Rege%20S%20V%20Maq,%20et%20al.%20Accelerated%20pericyte%20degeneration%20and%20blood-brain%20barrier%20breakdown%20in%20Apolipoprotein%20E4%20carriers%20with%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20J%20Cereb%20Blood%20Flow%20Metab.%202016;36(1):216%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Donahue Je, Flaherty S L, Johanson C E, et al. RAGE, LRP-1, and amyloid-beta protein in alzheimer’s disease [J]. Acta Neuropathol. 2006;112(4):405–15.
</cite> [<a href="https://doi.org/10.1007/s00401-006-0115-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16865397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donahue%20Je,%20Flaherty%20S%20L,%20Johanson%20C%20E,%20et%20al.%20RAGE,%20LRP-1,%20and%20amyloid-beta%20protein%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Acta%20Neuropathol.%202006;112(4):405%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Deane R, Wu Z. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms [J]. Neuron. 2004;43(3):333–44.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2004.07.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15294142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deane%20R,%20Wu%20Z.%20LRP/amyloid%20beta-peptide%20interaction%20mediates%20differential%20brain%20efflux%20of%20Abeta%20isoforms%20%5BJ%5D.%20Neuron.%202004;43(3):333%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Liu Cc, Hu J, Zhao N, et al. Astrocytic LRP1 mediates brain Abeta clearance and impacts amyloid deposition [J]. J Neurosci. 2017;37(15):4023–31.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3442-16.2017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5391682/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28275161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Cc,%20Hu%20J,%20Zhao%20N,%20et%20al.%20Astrocytic%20LRP1%20mediates%20brain%20Abeta%20clearance%20and%20impacts%20amyloid%20deposition%20%5BJ%5D.%20J%20Neurosci.%202017;37(15):4023%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Jiao H. Ginsenoside compound K acts via LRP1 to alleviate amyloid beta(42)-induced neuroinflammation in microglia by suppressing NF-kappaB [J]. Biochem Biophys Res Commun. 2022;590:14–9.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2021.12.071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34968779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiao%20H.%20Ginsenoside%20compound%20K%20acts%20via%20LRP1%20to%20alleviate%20amyloid%20beta(42)-induced%20neuroinflammation%20in%20microglia%20by%20suppressing%20NF-kappaB%20%5BJ%5D.%20Biochem%20Biophys%20Res%20Commun.%202022;590:14%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Chuang T Y, Guo Y, Seki S M, et al. LRP1 expression in microglia is protective during CNS autoimmunity [J]. Acta Neuropathol Commun. 2016;4(1):68.
</cite> [<a href="https://doi.org/10.1186/s40478-016-0343-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4940960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27400748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chuang%20T%20Y,%20Guo%20Y,%20Seki%20S%20M,%20et%20al.%20LRP1%20expression%20in%20microglia%20is%20protective%20during%20CNS%20autoimmunity%20%5BJ%5D.%20Acta%20Neuropathol%20Commun.%202016;4(1):68." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Brifault C, Kwon H, Campana W M, et al. LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal Horn and neuropathic pain processing [J]. Glia. 2019;67(6):1210–24.
</cite> [<a href="https://doi.org/10.1002/glia.23599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6462253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30746765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brifault%20C,%20Kwon%20H,%20Campana%20W%20M,%20et%20al.%20LRP1%20deficiency%20in%20microglia%20blocks%20neuro-inflammation%20in%20the%20spinal%20dorsal%20Horn%20and%20neuropathic%20pain%20processing%20%5BJ%5D.%20Glia.%202019;67(6):1210%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Wozniak D F Zerbinatticv, Cirrito J, et al. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein [J]. Proc Natl Acad Sci U S A. 2004;101(4):1075–80.
</cite> [<a href="https://doi.org/10.1073/pnas.0305803101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC327153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14732699/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wozniak%20D%20F%20Zerbinatticv,%20Cirrito%20J,%20et%20al.%20Increased%20soluble%20amyloid-beta%20peptide%20and%20memory%20deficits%20in%20amyloid%20model%20mice%20overexpressing%20the%20low-density%20lipoprotein%20receptor-related%20protein%20%5BJ%5D.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202004;101(4):1075%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Ulery P G, Beers J, Mikhailenko I, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of alzheimer’s disease [J]. J Biol Chem. 2000;275(10):7410–5.
</cite> [<a href="https://doi.org/10.1074/jbc.275.10.7410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10702315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ulery%20P%20G,%20Beers%20J,%20Mikhailenko%20I,%20et%20al.%20Modulation%20of%20beta-amyloid%20precursor%20protein%20processing%20by%20the%20low%20density%20lipoprotein%20receptor-related%20protein%20(LRP).%20Evidence%20that%20LRP%20contributes%20to%20the%20pathogenesis%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20J%20Biol%20Chem.%202000;275(10):7410%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Rebeck G W, Moir R D, Mui S, et al. Association of membrane-bound amyloid precursor protein APP with the Apolipoprotein E receptor LRP [J]. Brain Res Mol Brain Res. 2001;87(2):238–45.
</cite> [<a href="https://doi.org/10.1016/s0169-328x(01)00006-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11245926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rebeck%20G%20W,%20Moir%20R%20D,%20Mui%20S,%20et%20al.%20Association%20of%20membrane-bound%20amyloid%20precursor%20protein%20APP%20with%20the%20Apolipoprotein%20E%20receptor%20LRP%20%5BJ%5D.%20Brain%20Res%20Mol%20Brain%20Res.%202001;87(2):238%E2%80%9345." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Kanekiyo T, Cirrito J R, Liu C C, et al. Neuronal clearance of amyloid-beta by endocytic receptor LRP1 [J]. J Neurosci. 2013;33(49):19276–83.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.3487-13.2013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3850043/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24305823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanekiyo%20T,%20Cirrito%20J%20R,%20Liu%20C%20C,%20et%20al.%20Neuronal%20clearance%20of%20amyloid-beta%20by%20endocytic%20receptor%20LRP1%20%5BJ%5D.%20J%20Neurosci.%202013;33(49):19276%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Fuentealba Ra, Liu Q, Zhang J, et al. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking [J]. PLoS ONE. 2010;5(7):e11884.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0011884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2912373/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20686698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fuentealba%20Ra,%20Liu%20Q,%20Zhang%20J,%20et%20al.%20Low-density%20lipoprotein%20receptor-related%20protein%201%20(LRP1)%20mediates%20neuronal%20Abeta42%20uptake%20and%20lysosomal%20trafficking%20%5BJ%5D.%20PLoS%20ONE.%202010;5(7):e11884." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Rauch Jn, Luna G. LRP1 is a master regulator of Tau uptake and spread [J]. Nature. 2020;580(7803):381–5.
</cite> [<a href="https://doi.org/10.1038/s41586-020-2156-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7687380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32296178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rauch%20Jn,%20Luna%20G.%20LRP1%20is%20a%20master%20regulator%20of%20Tau%20uptake%20and%20spread%20%5BJ%5D.%20Nature.%202020;580(7803):381%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Tobert JA. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase [J]. Circulation. 1987;76(3):534–8.
</cite> [<a href="https://doi.org/10.1161/01.cir.76.3.534" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3113763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tobert%20JA.%20New%20developments%20in%20lipid-lowering%20therapy:%20the%20role%20of%20inhibitors%20of%20hydroxymethylglutaryl-coenzyme%20A%20reductase%20%5BJ%5D.%20Circulation.%201987;76(3):534%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Rise P, Ghezzi S. Galli C. Relative potencies of statins in reducing cholesterol synthesis and enhancing linoleic acid metabolism [J]. Eur J Pharmacol, 2003;467(1–3):73 – 5.</cite> [<a href="https://doi.org/10.1016/s0014-2999(03)01594-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12706457/" class="usa-link">PubMed</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>He Z, He X, Liu M et al. Simvastatin attenuates H(2)O(2)-Induced endothelial cell dysfunction by reducing Endoplasmic reticulum stress [J]. Molecules, 2019;24(9).</cite> [<a href="https://doi.org/10.3390/molecules24091782" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6539125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31071981/" class="usa-link">PubMed</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Balakumar P, Mahadevan N. Interplay between Statins and PPARs in improving cardiovascular outcomes: a double-edged sword? [J]. Br J Pharmacol. 2012;165(2):373–9.
</cite> [<a href="https://doi.org/10.1111/j.1476-5381.2011.01597.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3268191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21790534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balakumar%20P,%20Mahadevan%20N.%20Interplay%20between%20Statins%20and%20PPARs%20in%20improving%20cardiovascular%20outcomes:%20a%20double-edged%20sword?%20%5BJ%5D.%20Br%20J%20Pharmacol.%202012;165(2):373%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Calvier L, Herz J. Interplay of Low-Density lipoprotein receptors, lrps, and lipoproteins in pulmonary hypertension [J]. JACC Basic Transl Sci. 2022;7(2):164–80.
</cite> [<a href="https://doi.org/10.1016/j.jacbts.2021.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8897182/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35257044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Calvier%20L,%20Herz%20J.%20Interplay%20of%20Low-Density%20lipoprotein%20receptors,%20lrps,%20and%20lipoproteins%20in%20pulmonary%20hypertension%20%5BJ%5D.%20JACC%20Basic%20Transl%20Sci.%202022;7(2):164%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Goto T, Nagai H, Egawa K, et al. Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARgamma agonist [J]. Biochem J. 2011;438(1):111–9.
</cite> [<a href="https://doi.org/10.1042/BJ20101939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3253524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21605082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goto%20T,%20Nagai%20H,%20Egawa%20K,%20et%20al.%20Farnesyl%20pyrophosphate%20regulates%20adipocyte%20functions%20as%20an%20endogenous%20PPARgamma%20agonist%20%5BJ%5D.%20Biochem%20J.%202011;438(1):111%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Field F J, Born E, Murthy S, et al. Regulation of sterol regulatory element-binding proteins by cholesterol flux in CaCo-2 cells [J]. J Lipid Res. 2001;42(10):1687–98.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11590226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Field%20F%20J,%20Born%20E,%20Murthy%20S,%20et%20al.%20Regulation%20of%20sterol%20regulatory%20element-binding%20proteins%20by%20cholesterol%20flux%20in%20CaCo-2%20cells%20%5BJ%5D.%20J%20Lipid%20Res.%202001;42(10):1687%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Costales P, Aledo R, Vernia S, et al. Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression [J]. Atherosclerosis. 2010;213(2):458–68.
</cite> [<a href="https://doi.org/10.1016/j.atherosclerosis.2010.09.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20980003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Costales%20P,%20Aledo%20R,%20Vernia%20S,%20et%20al.%20Selective%20role%20of%20sterol%20regulatory%20element%20binding%20protein%20isoforms%20in%20aggregated%20LDL-induced%20vascular%20low%20density%20lipoprotein%20receptor-related%20protein-1%20expression%20%5BJ%5D.%20Atherosclerosis.%202010;213(2):458%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Lin T, Zeng L, Liu Y, et al. Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins [J]. Circ Res. 2003;92(12):1296–304.
</cite> [<a href="https://doi.org/10.1161/01.RES.0000078780.65824.8B" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12775580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20T,%20Zeng%20L,%20Liu%20Y,%20et%20al.%20Rho-ROCK-LIMK-cofilin%20pathway%20regulates%20shear%20stress%20activation%20of%20sterol%20regulatory%20element%20binding%20proteins%20%5BJ%5D.%20Circ%20Res.%202003;92(12):1296%E2%80%93304." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Andras I E, Eum S Y, Huang W, et al. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by Simvastatin [J]. Mol Cell Neurosci. 2010;43(2):232–43.
</cite> [<a href="https://doi.org/10.1016/j.mcn.2009.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2818553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19944163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andras%20I%20E,%20Eum%20S%20Y,%20Huang%20W,%20et%20al.%20HIV-1-induced%20amyloid%20beta%20accumulation%20in%20brain%20endothelial%20cells%20is%20attenuated%20by%20Simvastatin%20%5BJ%5D.%20Mol%20Cell%20Neurosci.%202010;43(2):232%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Zandl-Lang M, Fanaee-Danesh E, Sun Y, et al. Regulatory effects of Simvastatin and ApoJ on APP processing and amyloid-beta clearance in blood-brain barrier endothelial cells [J]. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(1):40–60.
</cite> [<a href="https://doi.org/10.1016/j.bbalip.2017.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28941799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zandl-Lang%20M,%20Fanaee-Danesh%20E,%20Sun%20Y,%20et%20al.%20Regulatory%20effects%20of%20Simvastatin%20and%20ApoJ%20on%20APP%20processing%20and%20amyloid-beta%20clearance%20in%20blood-brain%20barrier%20endothelial%20cells%20%5BJ%5D.%20Biochim%20Biophys%20Acta%20Mol%20Cell%20Biol%20Lipids.%202018;1863(1):40%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Wang X, Chen S, Xia X, et al. Lysosome-Targeting protein degradation through endocytosis pathway triggered by polyvalent Nano-Chimera for AD therapy [J]. Adv Mater. 2025;37(5):e2411061.
</cite> [<a href="https://doi.org/10.1002/adma.202411061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39686821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20X,%20Chen%20S,%20Xia%20X,%20et%20al.%20Lysosome-Targeting%20protein%20degradation%20through%20endocytosis%20pathway%20triggered%20by%20polyvalent%20Nano-Chimera%20for%20AD%20therapy%20%5BJ%5D.%20Adv%20Mater.%202025;37(5):e2411061." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Xia X, Wei Y, Huang Q, et al. Counteracting alzheimer’s disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator [J]. Acta Pharm Sin B. 2024;14(12):5464–78.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2024.05.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11725031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39807324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20X,%20Wei%20Y,%20Huang%20Q,%20et%20al.%20Counteracting%20alzheimer%E2%80%99s%20disease%20via%20normalizing%20neurovascular%20unit%20with%20a%20self-regulated%20multi-functional%20nano-modulator%20%5BJ%5D.%20Acta%20Pharm%20Sin%20B.%202024;14(12):5464%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Yang W, Shi Y, Zhang Y, et al. Intranasal Carrier-Free nanomodulator addresses both symptomatology and etiology of alzheimer’s disease by restoring neuron plasticity and reprogramming lesion microenvironment [J]. ACS Nano. 2024;18(43):29779–93.
</cite> [<a href="https://doi.org/10.1021/acsnano.4c09449" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39415568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20W,%20Shi%20Y,%20Zhang%20Y,%20et%20al.%20Intranasal%20Carrier-Free%20nanomodulator%20addresses%20both%20symptomatology%20and%20etiology%20of%20alzheimer%E2%80%99s%20disease%20by%20restoring%20neuron%20plasticity%20and%20reprogramming%20lesion%20microenvironment%20%5BJ%5D.%20ACS%20Nano.%202024;18(43):29779%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Tong X K, Nicolakakis N, Fernandes P, et al. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice [J]. Neurobiol Dis. 2009;35(3):406–14.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2009.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19524673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20X%20K,%20Nicolakakis%20N,%20Fernandes%20P,%20et%20al.%20Simvastatin%20improves%20cerebrovascular%20function%20and%20counters%20soluble%20amyloid-beta,%20inflammation%20and%20oxidative%20stress%20in%20aged%20APP%20mice%20%5BJ%5D.%20Neurobiol%20Dis.%202009;35(3):406%E2%80%9314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Guo Y, Zou G, Qi K, et al. Simvastatin impairs hippocampal synaptic plasticity and cognitive function in mice [J]. Mol Brain. 2021;14(1):41.
</cite> [<a href="https://doi.org/10.1186/s13041-021-00758-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7905661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33627175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20Y,%20Zou%20G,%20Qi%20K,%20et%20al.%20Simvastatin%20impairs%20hippocampal%20synaptic%20plasticity%20and%20cognitive%20function%20in%20mice%20%5BJ%5D.%20Mol%20Brain.%202021;14(1):41." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Guo Q, Zhu Q, Miao T, et al. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases [J]. J Control Release. 2019;303:117–29.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.04.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31026546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20Q,%20Zhu%20Q,%20Miao%20T,%20et%20al.%20LRP1-upregulated%20nanoparticles%20for%20efficiently%20conquering%20the%20blood-brain%20barrier%20and%20targetedly%20suppressing%20multifocal%20and%20infiltrative%20brain%20metastases%20%5BJ%5D.%20J%20Control%20Release.%202019;303:117%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Jana A, Wang X, Leasure J W, et al. Increased type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of alzheimer’s disease [J]. Sci Rep. 2022;12(1):16488.
</cite> [<a href="https://doi.org/10.1038/s41598-022-20889-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9526723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36182964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jana%20A,%20Wang%20X,%20Leasure%20J%20W,%20et%20al.%20Increased%20type%20I%20interferon%20signaling%20and%20brain%20endothelial%20barrier%20dysfunction%20in%20an%20experimental%20model%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Sci%20Rep.%202022;12(1):16488." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Deng Q S, Dong X Y, Wu H, et al. Disrupted-in-Schizophrenia-1 attenuates Amyloid-beta generation and cognitive deficits in APP/PS1 Transgenic mice by reduction of beta-Site APP-Cleaving enzyme 1 levels [J]. Neuropsychopharmacology. 2016;41(2):440–53.
</cite> [<a href="https://doi.org/10.1038/npp.2015.164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5130120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26062786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20Q%20S,%20Dong%20X%20Y,%20Wu%20H,%20et%20al.%20Disrupted-in-Schizophrenia-1%20attenuates%20Amyloid-beta%20generation%20and%20cognitive%20deficits%20in%20APP/PS1%20Transgenic%20mice%20by%20reduction%20of%20beta-Site%20APP-Cleaving%20enzyme%201%20levels%20%5BJ%5D.%20Neuropsychopharmacology.%202016;41(2):440%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Zhang J, Chen Y, Zhao Y, et al. Terahertz irradiation improves cognitive impairments and attenuates alzheimer’s neuropathology in the APP(SWE)/PS1(DE9) mouse: A novel therapeutic intervention for alzheimer’s disease [J]. Neurosci Bull. 2024;40(7):857–71.
</cite> [<a href="https://doi.org/10.1007/s12264-023-01145-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11250709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37971654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Chen%20Y,%20Zhao%20Y,%20et%20al.%20Terahertz%20irradiation%20improves%20cognitive%20impairments%20and%20attenuates%20alzheimer%E2%80%99s%20neuropathology%20in%20the%20APP(SWE)/PS1(DE9)%20mouse:%20A%20novel%20therapeutic%20intervention%20for%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Neurosci%20Bull.%202024;40(7):857%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Zhu Y, Huang H, Chen Z, et al. Intermittent theta burst stimulation attenuates cognitive deficits and alzheimer’s Disease-Type pathologies via ISCA1-Mediated mitochondrial modulation in APP/PS1 mice [J]. Neurosci Bull. 2024;40(2):182–200.
</cite> [<a href="https://doi.org/10.1007/s12264-023-01098-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10838862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37578635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20Y,%20Huang%20H,%20Chen%20Z,%20et%20al.%20Intermittent%20theta%20burst%20stimulation%20attenuates%20cognitive%20deficits%20and%20alzheimer%E2%80%99s%20Disease-Type%20pathologies%20via%20ISCA1-Mediated%20mitochondrial%20modulation%20in%20APP/PS1%20mice%20%5BJ%5D.%20Neurosci%20Bull.%202024;40(2):182%E2%80%93200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Marino S M, Gladyshev V N. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces [J]. J Mol Biol. 2010;404(5):902–16.
</cite> [<a href="https://doi.org/10.1016/j.jmb.2010.09.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3061813/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20950627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marino%20S%20M,%20Gladyshev%20V%20N.%20Cysteine%20function%20governs%20its%20conservation%20and%20degeneration%20and%20restricts%20its%20utilization%20on%20protein%20surfaces%20%5BJ%5D.%20J%20Mol%20Biol.%202010;404(5):902%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Wang C W, Nan D D, Wang X M, et al. A peptide-based near-infrared fluorescence probe for dynamic monitoring senile plaques in alzheimer’s disease mouse model [J]. Sci Bull (Beijing). 2017;62(23):1593–601.
</cite> [<a href="https://doi.org/10.1016/j.scib.2017.11.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36659477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20C%20W,%20Nan%20D%20D,%20Wang%20X%20M,%20et%20al.%20A%20peptide-based%20near-infrared%20fluorescence%20probe%20for%20dynamic%20monitoring%20senile%20plaques%20in%20alzheimer%E2%80%99s%20disease%20mouse%20model%20%5BJ%5D.%20Sci%20Bull%20(Beijing).%202017;62(23):1593%E2%80%93601." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Patil R, Sun T, Rashid M H et al. Multifunctional nanopolymers for Blood-Brain barrier delivery and Inhibition of glioblastoma growth through egfr/egfrviii, c-Myc, and PD-1 [J]. Nanomaterials (Basel), 2021;11(11).</cite> [<a href="https://doi.org/10.3390/nano11112892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8621221/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34835657/" class="usa-link">PubMed</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Miao T T, Ju X F, ZHU Q N et al. Nanoparticles surmounting Blood-Brain tumor barrier through both transcellular and paracellular pathways to target brain metastases [J]. Adv Funct Mater, 2019;29(27).</cite>
</li>
<li id="CR74">
<span class="label">74.</span><cite>Pluvinage J V, Haney M S, SMITH B A H, et al. CD22 Blockade restores homeostatic microglial phagocytosis in ageing brains [J]. Nature. 2019;568(7751):187–92.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1088-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6574119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30944478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pluvinage%20J%20V,%20Haney%20M%20S,%20SMITH%20B%20A%20H,%20et%20al.%20CD22%20Blockade%20restores%20homeostatic%20microglial%20phagocytosis%20in%20ageing%20brains%20%5BJ%5D.%20Nature.%202019;568(7751):187%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Jean Y Y, Baleriola J. Fa M, Stereotaxic infusion of oligomeric Amyloid-beta into the mouse hippocampus [J]. J Vis Exp, 2015;(100):e52805.</cite> [<a href="https://doi.org/10.3791/52805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4545125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26132278/" class="usa-link">PubMed</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Di Polidoro A C, Cafarchio A, Vecchione D et al. Revealing Angiopep-2/LRP1 molecular interaction for optimal delivery to glioblastoma (GBM) [J]. Molecules, 2022;27(19).</cite> [<a href="https://doi.org/10.3390/molecules27196696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9572160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36235232/" class="usa-link">PubMed</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Demeule M, Currie J C, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2 [J]. J Neurochem. 2008;106(4):1534–44.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2008.05492.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18489712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Demeule%20M,%20Currie%20J%20C,%20Bertrand%20Y,%20et%20al.%20Involvement%20of%20the%20low-density%20lipoprotein%20receptor-related%20protein%20in%20the%20transcytosis%20of%20the%20brain%20delivery%20vector%20angiopep-2%20%5BJ%5D.%20J%20Neurochem.%202008;106(4):1534%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Khan N U, Ni J, Ju X, et al. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment [J]. Acta Pharm Sin B. 2021;11(5):1341–54.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2020.10.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8148067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34094838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khan%20N%20U,%20Ni%20J,%20Ju%20X,%20et%20al.%20Escape%20from%20abluminal%20LRP1-mediated%20clearance%20for%20boosted%20nanoparticle%20brain%20delivery%20and%20brain%20metastasis%20treatment%20%5BJ%5D.%20Acta%20Pharm%20Sin%20B.%202021;11(5):1341%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Minkeviciene R, Ihalainen J, Malm T, et al. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 Transgenic and wild-type mice [J]. J Neurochem. 2008;105(3):584–94.
</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2007.05147.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18042177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Minkeviciene%20R,%20Ihalainen%20J,%20Malm%20T,%20et%20al.%20Age-related%20decrease%20in%20stimulated%20glutamate%20release%20and%20vesicular%20glutamate%20transporters%20in%20APP/PS1%20Transgenic%20and%20wild-type%20mice%20%5BJ%5D.%20J%20Neurochem.%202008;105(3):584%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Zhu S, Wang J, Zhang Y, et al. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 Transgenic mouse model of alzheimer’s disease [J]. CNS Neurosci Ther. 2017;23(4):310–20.
</cite> [<a href="https://doi.org/10.1111/cns.12677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6492725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28191738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20S,%20Wang%20J,%20Zhang%20Y,%20et%20al.%20The%20role%20of%20neuroinflammation%20and%20amyloid%20in%20cognitive%20impairment%20in%20an%20APP/PS1%20Transgenic%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20CNS%20Neurosci%20Ther.%202017;23(4):310%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Kaya M. Basic physiology of the blood-brain barrier in health and disease: a brief overview [J]. Tissue Barriers. 2021;9(1):1840913.
</cite> [<a href="https://doi.org/10.1080/21688370.2020.1840913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7849738/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33190576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kaya%20M.%20Basic%20physiology%20of%20the%20blood-brain%20barrier%20in%20health%20and%20disease:%20a%20brief%20overview%20%5BJ%5D.%20Tissue%20Barriers.%202021;9(1):1840913." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Chow B W Kaplanl. Neuronal regulation of the blood-brain barrier and neurovascular coupling [J]. Nat Rev Neurosci. 2020;21(8):416–32.
</cite> [<a href="https://doi.org/10.1038/s41583-020-0322-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8934575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32636528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chow%20B%20W%20Kaplanl.%20Neuronal%20regulation%20of%20the%20blood-brain%20barrier%20and%20neurovascular%20coupling%20%5BJ%5D.%20Nat%20Rev%20Neurosci.%202020;21(8):416%E2%80%9332." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Lacoste B, Comin C H, Ben-Zvi A, et al. Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex [J]. Neuron. 2014;83(5):1117–30.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2014.07.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4166422/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25155955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lacoste%20B,%20Comin%20C%20H,%20Ben-Zvi%20A,%20et%20al.%20Sensory-related%20neural%20activity%20regulates%20the%20structure%20of%20vascular%20networks%20in%20the%20cerebral%20cortex%20%5BJ%5D.%20Neuron.%202014;83(5):1117%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Bell Rd, Sagare A P, Friedman A E, et al. Transport pathways for clearance of human alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system [J]. J Cereb Blood Flow Metab. 2007;27(5):909–18.
</cite> [<a href="https://doi.org/10.1038/sj.jcbfm.9600419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2853021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17077814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bell%20Rd,%20Sagare%20A%20P,%20Friedman%20A%20E,%20et%20al.%20Transport%20pathways%20for%20clearance%20of%20human%20alzheimer%E2%80%99s%20amyloid%20beta-peptide%20and%20apolipoproteins%20E%20and%20J%20in%20the%20mouse%20central%20nervous%20system%20%5BJ%5D.%20J%20Cereb%20Blood%20Flow%20Metab.%202007;27(5):909%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Ji Y, Permanne B Sigurdssonem, et al. Amyloid beta40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, ApoE knock-out and human ApoE3 or E4 expressing Transgenic mice [J]. J Alzheimers Dis. 2001;3(1):23–30.
</cite> [<a href="https://doi.org/10.3233/jad-2001-3105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12214069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ji%20Y,%20Permanne%20B%20Sigurdssonem,%20et%20al.%20Amyloid%20beta40/42%20clearance%20across%20the%20blood-brain%20barrier%20following%20intra-ventricular%20injections%20in%20wild-type,%20ApoE%20knock-out%20and%20human%20ApoE3%20or%20E4%20expressing%20Transgenic%20mice%20%5BJ%5D.%20J%20Alzheimers%20Dis.%202001;3(1):23%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Hampel H, Hardy J, Blennow K, et al. The Amyloid-beta pathway in alzheimer’s disease [J]. Mol Psychiatry. 2021;26(10):5481–503.
</cite> [<a href="https://doi.org/10.1038/s41380-021-01249-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8758495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34456336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hampel%20H,%20Hardy%20J,%20Blennow%20K,%20et%20al.%20The%20Amyloid-beta%20pathway%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Mol%20Psychiatry.%202021;26(10):5481%E2%80%93503." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Devraj K, Poznanovic S, Spahn C, et al. BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of alzheimer’s disease [J]. J Cereb Blood Flow Metab. 2016;36(7):1281–94.
</cite> [<a href="https://doi.org/10.1177/0271678X15606463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4929696/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26661166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Devraj%20K,%20Poznanovic%20S,%20Spahn%20C,%20et%20al.%20BACE-1%20is%20expressed%20in%20the%20blood-brain%20barrier%20endothelium%20and%20is%20upregulated%20in%20a%20murine%20model%20of%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20J%20Cereb%20Blood%20Flow%20Metab.%202016;36(7):1281%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Kandalepas Pc, Sadleir K R, EIMER W A, et al. The alzheimer’s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques [J]. Acta Neuropathol. 2013;126(3):329–52.
</cite> [<a href="https://doi.org/10.1007/s00401-013-1152-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3753469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23820808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kandalepas%20Pc,%20Sadleir%20K%20R,%20EIMER%20W%20A,%20et%20al.%20The%20alzheimer%E2%80%99s%20beta-secretase%20BACE1%20localizes%20to%20normal%20presynaptic%20terminals%20and%20to%20dystrophic%20presynaptic%20terminals%20surrounding%20amyloid%20plaques%20%5BJ%5D.%20Acta%20Neuropathol.%202013;126(3):329%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Von Einem B Schwanzard, Rehn F, et al. The role of low-density receptor-related protein 1 (LRP1) as a competitive substrate of the amyloid precursor protein (APP) for BACE1 [J]. Exp Neurol. 2010;225(1):85–93.
</cite> [<a href="https://doi.org/10.1016/j.expneurol.2010.05.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20685197/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Von%20Einem%20B%20Schwanzard,%20Rehn%20F,%20et%20al.%20The%20role%20of%20low-density%20receptor-related%20protein%201%20(LRP1)%20as%20a%20competitive%20substrate%20of%20the%20amyloid%20precursor%20protein%20(APP)%20for%20BACE1%20%5BJ%5D.%20Exp%20Neurol.%202010;225(1):85%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Tanokashira D, Motoki K, Minegishi S et al. LRP1 Downregulates the Alzheimer’s beta-Secretase BACE1 by Modulating Its Intraneuronal Trafficking [J]. eNeuro, 2015;2(2).</cite> [<a href="https://doi.org/10.1523/ENEURO.0006-15.2015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4596091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26464978/" class="usa-link">PubMed</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Wang Z T, Lu M H, Zhang Y, et al. Disrupted-in-schizophrenia-1 protects synaptic plasticity in a Transgenic mouse model of alzheimer’s disease as a mitophagy receptor [J]. Aging Cell. 2019;18(1):e12860.
</cite> [<a href="https://doi.org/10.1111/acel.12860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6351828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30488644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z%20T,%20Lu%20M%20H,%20Zhang%20Y,%20et%20al.%20Disrupted-in-schizophrenia-1%20protects%20synaptic%20plasticity%20in%20a%20Transgenic%20mouse%20model%20of%20alzheimer%E2%80%99s%20disease%20as%20a%20mitophagy%20receptor%20%5BJ%5D.%20Aging%20Cell.%202019;18(1):e12860." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Chami L, Checler F. Bace1 Is at the crossroad of a toxic vicious cycle involving cellular stress and beta-amyloid production in alzheimer’s disease [J]. Mol Neurodegener. 2012;7:52.
</cite> [<a href="https://doi.org/10.1186/1750-1326-7-52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3507664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23039869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chami%20L,%20Checler%20F.%20Bace1%20Is%20at%20the%20crossroad%20of%20a%20toxic%20vicious%20cycle%20involving%20cellular%20stress%20and%20beta-amyloid%20production%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20Mol%20Neurodegener.%202012;7:52." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Fakhoury M. Microglia and Astrocytes in Alzheimer’s Disease: Implications for Therapy [J]. Curr Neuropharmacol, 2018;16(5):508–18.</cite> [<a href="https://doi.org/10.2174/1570159X15666170720095240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5997862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28730967/" class="usa-link">PubMed</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Hansen D V, Hanson J E Shengm. Microglia in alzheimer’s disease [J]. J Cell Biol. 2018;217(2):459–72.
</cite> [<a href="https://doi.org/10.1083/jcb.201709069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5800817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29196460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hansen%20D%20V,%20Hanson%20J%20E%20Shengm.%20Microglia%20in%20alzheimer%E2%80%99s%20disease%20%5BJ%5D.%20J%20Cell%20Biol.%202018;217(2):459%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease [J]. J Neuroinflammation, 2022;19(1):206.</cite> [<a href="https://doi.org/10.1186/s12974-022-02565-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9382837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35978311/" class="usa-link">PubMed</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Tzioras M, Mcgeachan R I, Durrant C S, et al. Synaptic degeneration in alzheimer disease [J]. Nat Rev Neurol. 2023;19(1):19–38.
</cite> [<a href="https://doi.org/10.1038/s41582-022-00749-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36513730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tzioras%20M,%20Mcgeachan%20R%20I,%20Durrant%20C%20S,%20et%20al.%20Synaptic%20degeneration%20in%20alzheimer%20disease%20%5BJ%5D.%20Nat%20Rev%20Neurol.%202023;19(1):19%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Antunes M. The novel object recognition memory: neurobiology, test procedure, and its modifications [J]. Cogn Process. 2012;13(2):93–110.
</cite> [<a href="https://doi.org/10.1007/s10339-011-0430-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3332351/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22160349/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Antunes%20M.%20The%20novel%20object%20recognition%20memory:%20neurobiology,%20test%20procedure,%20and%20its%20modifications%20%5BJ%5D.%20Cogn%20Process.%202012;13(2):93%E2%80%93110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Murai T, Okuda S, Tanaka T, et al. Characteristics of object location memory in mice: behavioral and Pharmacological studies [J]. Physiol Behav. 2007;90(1):116–24.
</cite> [<a href="https://doi.org/10.1016/j.physbeh.2006.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17049363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murai%20T,%20Okuda%20S,%20Tanaka%20T,%20et%20al.%20Characteristics%20of%20object%20location%20memory%20in%20mice:%20behavioral%20and%20Pharmacological%20studies%20%5BJ%5D.%20Physiol%20Behav.%202007;90(1):116%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Li S, Kumar T P Joshees, et al. Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior [J]. Cell Res. 2018;28(2):221–48.
</cite> [<a href="https://doi.org/10.1038/cr.2017.135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5799810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29086765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20S,%20Kumar%20T%20P%20Joshees,%20et%20al.%20Endothelial%20cell-derived%20GABA%20signaling%20modulates%20neuronal%20migration%20and%20postnatal%20behavior%20%5BJ%5D.%20Cell%20Res.%202018;28(2):221%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Marottoli F M, Zhang H, Flores-Barrera E, et al. Endothelial cell APOE3 regulates neurovascular, neuronal, and behavioral function [J]. Arterioscler Thromb Vasc Biol. 2023;43(10):1952–66.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.123.319816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10521805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37650329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marottoli%20F%20M,%20Zhang%20H,%20Flores-Barrera%20E,%20et%20al.%20Endothelial%20cell%20APOE3%20regulates%20neurovascular,%20neuronal,%20and%20behavioral%20function%20%5BJ%5D.%20Arterioscler%20Thromb%20Vasc%20Biol.%202023;43(10):1952%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Huang J, Zhang G, LI S, et al. Endothelial cell-derived exosomes boost and maintain repair-related phenotypes of Schwann cells via miR199-5p to promote nerve regeneration [J]. J Nanobiotechnol. 2023;21(1):10.</cite> [<a href="https://doi.org/10.1186/s12951-023-01767-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9827708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36624511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20J,%20Zhang%20G,%20LI%20S,%20et%20al.%20Endothelial%20cell-derived%20exosomes%20boost%20and%20maintain%20repair-related%20phenotypes%20of%20Schwann%20cells%20via%20miR199-5p%20to%20promote%20nerve%20regeneration%20%5BJ%5D.%20J%20Nanobiotechnol.%202023;21(1):10." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Swire M, Kotelevtsev Y, Webb D J et al. Endothelin signalling mediates experience-dependent myelination in the CNS [J]. Elife, 2019;8:e49493.</cite> [<a href="https://doi.org/10.7554/eLife.49493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6831104/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31657718/" class="usa-link">PubMed</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>MA D, Zhang H. Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway [J]. Glia. 2024;72(1):133–55.
</cite> [<a href="https://doi.org/10.1002/glia.24466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37675625/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?MA%20D,%20Zhang%20H.%20Human%20iPSC-derived%20endothelial%20cells%20promote%20CNS%20remyelination%20via%20BDNF%20and%20mTORC1%20pathway%20%5BJ%5D.%20Glia.%202024;72(1):133%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Ruiz F, Peter B, Rebeaud J, et al. Endothelial cell-derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis [J]. EMBO Rep. 2023;24(3):e55328.
</cite> [<a href="https://doi.org/10.15252/embr.202255328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9986812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36715148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruiz%20F,%20Peter%20B,%20Rebeaud%20J,%20et%20al.%20Endothelial%20cell-derived%20oxysterol%20ablation%20attenuates%20experimental%20autoimmune%20encephalomyelitis%20%5BJ%5D.%20EMBO%20Rep.%202023;24(3):e55328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Wei C, Jiang W, Wang R, et al. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown [J]. Nature. 2024;629(8013):893–900.
</cite> [<a href="https://doi.org/10.1038/s41586-024-07314-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38632402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20C,%20Jiang%20W,%20Wang%20R,%20et%20al.%20Brain%20endothelial%20GSDMD%20activation%20mediates%20inflammatory%20BBB%20breakdown%20%5BJ%5D.%20Nature.%202024;629(8013):893%E2%80%93900." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Chen X H, Johnson V E, Uryu K, et al. A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury [J]. Brain Pathol. 2009;19(2):214–23.
</cite> [<a href="https://doi.org/10.1111/j.1750-3639.2008.00176.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3014260/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18492093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X%20H,%20Johnson%20V%20E,%20Uryu%20K,%20et%20al.%20A%20lack%20of%20amyloid%20beta%20plaques%20despite%20persistent%20accumulation%20of%20amyloid%20beta%20in%20axons%20of%20long-term%20survivors%20of%20traumatic%20brain%20injury%20%5BJ%5D.%20Brain%20Pathol.%202009;19(2):214%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Katusic Z S, D’uscio L V Het. Cerebrovascular endothelial dysfunction: role of BACE1 [J]. Arterioscler Thromb Vasc Biol. 2024;44(8):1737–47.
</cite> [<a href="https://doi.org/10.1161/ATVBAHA.124.320798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11269044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38868939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Katusic%20Z%20S,%20D%E2%80%99uscio%20L%20V%20Het.%20Cerebrovascular%20endothelial%20dysfunction:%20role%20of%20BACE1%20%5BJ%5D.%20Arterioscler%20Thromb%20Vasc%20Biol.%202024;44(8):1737%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Zhou H, Gao F, Yang X, et al. Endothelial BACE1 impairs cerebral small vessels via tight junctions and eNOS [J]. Circ Res. 2022;130(9):1321–41.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.121.320183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35382554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20H,%20Gao%20F,%20Yang%20X,%20et%20al.%20Endothelial%20BACE1%20impairs%20cerebral%20small%20vessels%20via%20tight%20junctions%20and%20eNOS%20%5BJ%5D.%20Circ%20Res.%202022;130(9):1321%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Dalla Y, Singh N Jaggias, et al. Memory restorative role of Statins in experimental dementia: an evidence of their cholesterol dependent and independent actions [J]. Pharmacol Rep. 2010;62(5):784–96.
</cite> [<a href="https://doi.org/10.1016/s1734-1140(10)70339-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21098862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dalla%20Y,%20Singh%20N%20Jaggias,%20et%20al.%20Memory%20restorative%20role%20of%20Statins%20in%20experimental%20dementia:%20an%20evidence%20of%20their%20cholesterol%20dependent%20and%20independent%20actions%20%5BJ%5D.%20Pharmacol%20Rep.%202010;62(5):784%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Soares E A, Novaes R D, Nakagaki W R, et al. Metabolic and structural bone disturbances induced by hyperlipidic diet in mice treated with Simvastatin [J]. Int J Exp Pathol. 2015;96(4):261–8.
</cite> [<a href="https://doi.org/10.1111/iep.12134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4561563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26175225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Soares%20E%20A,%20Novaes%20R%20D,%20Nakagaki%20W%20R,%20et%20al.%20Metabolic%20and%20structural%20bone%20disturbances%20induced%20by%20hyperlipidic%20diet%20in%20mice%20treated%20with%20Simvastatin%20%5BJ%5D.%20Int%20J%20Exp%20Pathol.%202015;96(4):261%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Vandenbark A A, Offner H, Matejuk S, et al. Microglia and astrocyte involvement in neurodegeneration and brain cancer [J]. J Neuroinflammation. 2021;18(1):298.
</cite> [<a href="https://doi.org/10.1186/s12974-021-02355-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8697466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34949203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vandenbark%20A%20A,%20Offner%20H,%20Matejuk%20S,%20et%20al.%20Microglia%20and%20astrocyte%20involvement%20in%20neurodegeneration%20and%20brain%20cancer%20%5BJ%5D.%20J%20Neuroinflammation.%202021;18(1):298." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Dudvarski Stankovic N, Teodorczyk M, Ploen R, et al. Microglia-blood vessel interactions: a double-edged sword in brain pathologies [J]. Acta Neuropathol. 2016;131(3):347–63.
</cite> [<a href="https://doi.org/10.1007/s00401-015-1524-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26711460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dudvarski%20Stankovic%20N,%20Teodorczyk%20M,%20Ploen%20R,%20et%20al.%20Microglia-blood%20vessel%20interactions:%20a%20double-edged%20sword%20in%20brain%20pathologies%20%5BJ%5D.%20Acta%20Neuropathol.%202016;131(3):347%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Thurgur H. Microglia in the neurovascular unit: Blood-Brain Barrier-microglia interactions after central nervous system disorders [J]. Neuroscience. 2019;405:55–67.
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2018.06.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31007172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thurgur%20H.%20Microglia%20in%20the%20neurovascular%20unit:%20Blood-Brain%20Barrier-microglia%20interactions%20after%20central%20nervous%20system%20disorders%20%5BJ%5D.%20Neuroscience.%202019;405:55%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Burkhart A, Helgudottir S S, Mahamed Y A, et al. Activation of glial cells induces Proinflammatory properties in brain capillary endothelial cells in vitro [J]. Sci Rep. 2024;14(1):26580.
</cite> [<a href="https://doi.org/10.1038/s41598-024-78204-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11535503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39496829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burkhart%20A,%20Helgudottir%20S%20S,%20Mahamed%20Y%20A,%20et%20al.%20Activation%20of%20glial%20cells%20induces%20Proinflammatory%20properties%20in%20brain%20capillary%20endothelial%20cells%20in%20vitro%20%5BJ%5D.%20Sci%20Rep.%202024;14(1):26580." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Du C, Hou J, Wang C, et al. Effects of safflower yellow on cholesterol levels in serum and brain tissue of APP/PS1 mice [J]. Metab Brain Dis. 2021;36(4):557–69.
</cite> [<a href="https://doi.org/10.1007/s11011-021-00680-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33550459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Du%20C,%20Hou%20J,%20Wang%20C,%20et%20al.%20Effects%20of%20safflower%20yellow%20on%20cholesterol%20levels%20in%20serum%20and%20brain%20tissue%20of%20APP/PS1%20mice%20%5BJ%5D.%20Metab%20Brain%20Dis.%202021;36(4):557%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Bai Y R, Wang Y Y, Meng D L, et al. Alterations of fatty acid composition and metabolism in APP/PS1 Transgenic mice [J]. Neurosci Lett. 2020;738:135401.
</cite> [<a href="https://doi.org/10.1016/j.neulet.2020.135401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32976920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bai%20Y%20R,%20Wang%20Y%20Y,%20Meng%20D%20L,%20et%20al.%20Alterations%20of%20fatty%20acid%20composition%20and%20metabolism%20in%20APP/PS1%20Transgenic%20mice%20%5BJ%5D.%20Neurosci%20Lett.%202020;738:135401." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Zeng W, Deng H, Luo Y et al. Advances in Statin adverse reactions and the potential mechanisms: A systematic review [J]. J Adv Res, 2024;S2090–1232(24)00598-8.</cite> [<a href="https://doi.org/10.1016/j.jare.2024.12.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39681285/" class="usa-link">PubMed</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Xiao M, Li L, Zhu W, et al. Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system [J]. Expert Rev Clin Pharmacol. 2024;17(3):255–61.
</cite> [<a href="https://doi.org/10.1080/17512433.2024.2311875" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38275183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiao%20M,%20Li%20L,%20Zhu%20W,%20et%20al.%20Statin-related%20neurocognitive%20disorder:%20a%20real-world%20pharmacovigilance%20study%20based%20on%20the%20FDA%20adverse%20event%20reporting%20system%20%5BJ%5D.%20Expert%20Rev%20Clin%20Pharmacol.%202024;17(3):255%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Evans M A, Golomb Ba. Statin-associated adverse cognitive effects: survey results from 171 patients [J]. Pharmacotherapy. 2009;29(7):800–11.
</cite> [<a href="https://doi.org/10.1592/phco.29.7.800" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19558254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Evans%20M%20A,%20Golomb%20Ba.%20Statin-associated%20adverse%20cognitive%20effects:%20survey%20results%20from%20171%20patients%20%5BJ%5D.%20Pharmacotherapy.%202009;29(7):800%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Zz Px, Gg L. The role of LRP1 in Abeta efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus [J]. Neurochem Int. 2022;160:105417.
</cite> [<a href="https://doi.org/10.1016/j.neuint.2022.105417" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36067928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zz%20Px,%20Gg%20L.%20The%20role%20of%20LRP1%20in%20Abeta%20efflux%20transport%20across%20the%20blood-brain%20barrier%20and%20cognitive%20dysfunction%20in%20diabetes%20mellitus%20%5BJ%5D.%20Neurochem%20Int.%202022;160:105417." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Chandrashekar D V, Roules G C, Jagadeesan N, et al. Hepatic LRP-1 plays an important role in amyloidosis in alzheimer’s disease mice: potential role in chronic heavy alcohol feeding [J]. Neurobiol Dis. 2024;199:106570.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2024.106570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11845272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38885850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chandrashekar%20D%20V,%20Roules%20G%20C,%20Jagadeesan%20N,%20et%20al.%20Hepatic%20LRP-1%20plays%20an%20important%20role%20in%20amyloidosis%20in%20alzheimer%E2%80%99s%20disease%20mice:%20potential%20role%20in%20chronic%20heavy%20alcohol%20feeding%20%5BJ%5D.%20Neurobiol%20Dis.%202024;199:106570." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366182/bin/13195_2025_1840_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (8.7MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366182/bin/13195_2025_1840_MOESM2_ESM.xls" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (95KB, xls) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that supports the conclusions of this study are available in the paper and/or the Supplementary material.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Alzheimer's Research &amp; Therapy are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13195-025-01840-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13195_2025_Article_1840.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (24.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366182/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366182/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366182%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366182/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366182/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366182/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830501/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366182/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830501/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366182/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366182/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ZOB1lB0tyofnTXihFjiLmAcS1f9VtsQZ5NcAK0QHNVq9GbOpM9XvlJjntCr5Xrlu">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
